Christopher Flowers MD, MS
Academic Appointment
- Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
- Adjunct Assistant Professor, Georgia Institute of Technology School of Industrial and Systems Engineering
Education
Degrees
- MS from University of Washington
- MS from Standford University
- MD from Standford Univeristy School of Medicine
- BA from Standford University
Research
Focus
- As director of Emory's Lymphoma Program, I seek to develop a program aimed at attaining international leadership and risk-adapted, individualized patient care. My clinical research interests are in the areas of population sciences, translational research, and clinical trails and evidence- based treatment and care for patients with lymphoid malignancies.
Publications
-
Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma.
Leuk Lymphoma Volume: 66 Page(s): 956 - 960
05/01/2025 Authors: Gaulin C; Jain P; Nair R; Iyer SP; Lee HJ; Fayad L; Feng L; Ok CY; Kanagal-Shamanna R; Oriabure O -
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel.
Blood Adv
04/08/2025 Authors: Saha S; Rehman L; Rehman A; Darbaniyan F; Weber DM; Becnel M; Gaballa MR; Thomas SK; Lee HC; Chang C-C -
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas.
Blood Adv Volume: 9 Page(s): 1485 - 1491
04/08/2025 Authors: Chihara D; Steiner RE; Nair R; Feng L; Ahmed S; Strati P; Malpica L; Griffith DP; Mathew SA; Montinez W -
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy.
JAMA Netw Open Volume: 8 Page(s): e253455
04/01/2025 Authors: Long JP; Prakash R; Edelkamp P; Knafl M; Lionel AC; Nair R; Ahmed S; Strati P; Castillo LEM; Al-Zaki A -
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 25 Page(s): e183 - e199.e8
04/01/2025 Authors: Nastoupil LJ; Andersen CR; Ayers A; Wang Y; Habermann TM; Chihara D; Kahl BS; Link BK; Koff JL; Cohen JB -
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.
Am J Hematol Volume: 100 Page(s): 606 - 615
04/01/2025 Authors: Yamshon S; Koff JL; Larson MC; Kahl BS; Casulo C; Lossos IS; Haddadi S; Stanchina M; Chihara D; Ayers A -
Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement.
Blood
03/16/2025 Authors: Yang H; Zhang W; Ravanmehr V; Cui G; Bowman K; Chen R; Henderson J; Lockman SR; Rojas E; Wilson AL -
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes.
Blood Adv
03/15/2025 Authors: Trnn M; Fogliato LM; Gardner F; Flinn IW; Larouche J-F; Haioun C; Canales MA; Goto H; Hajek R; Salles GA -
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium.
Blood Adv Volume: 9 Page(s): 1013 - 1023
03/11/2025 Authors: Day JR; Larson MC; Durani U; Koff JL; Wang Y; Habermann TM; Lossos IS; Nastoupil LJ; Strouse C; Chihara D -
Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach.
Blood Cancer Discov Volume: 6 Page(s): 79 - 93
03/04/2025 Authors: Flowers CR; Anantha RW; Leautaud V; Desai P; Donald CE; Hildebrandt MAT; Koff JL; Tamimi RM; Cozen W; Nze C -
End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?
Blood
02/28/2025 Authors: Di M; Maurer MJ; Flowers CR -
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy.
Blood Volume: 145 Page(s): 823 - 839
02/20/2025 Authors: Prasad R; Rehman A; Rehman L; Darbaniyan F; Blumenberg V; Schubert M-L; Mor U; Zamir E; Schmidt S; Hayase T -
New Approvals Advancing Blood Cancer Medicine.
Blood Cancer Discov Volume: 6 Page(s): 5 - 9
01/08/2025 Authors: AACR Cancer Progress Report 2024 Steering Committee -
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas.
Front Immunol Volume: 16 Page(s): 1517348
01/01/2025 Authors: Manzar GS; Pinnix CC; Dudzinski SO; Marqueen KE; Cha EE; Nasr LF; Yoder AK; Rooney MK; Strati P; Ahmed S -
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.
Front Immunol Volume: 16 Page(s): 1449693
01/01/2025 Authors: Lyu M-A; Tang X; Raso MG; Huang M; Zeng K; Sadeghi T; Flowers CR; Parmar S -
American Society of Hematology: building a comprehensive minority recruitment and retention professional program.
Blood Adv Volume: 8 Page(s): 6237 - 6247
12/24/2024 Authors: Rollins MR; Warsame RM; Smith M; Molina A; Rouce RH; Avalos BR; Johnson CS; Lopez JA; Thompson AA; Fanning L -
Cancer in 2024.
Cancer Discov Volume: 14 Page(s): 2324 - 2331
12/02/2024 Authors: AACR Cancer Disparities Progress Report 2024 Steering Committee; AACR Cancer Progress Report 2024 Steering Committee -
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
Adv Radiat Oncol Volume: 9 Page(s): 101650
12/01/2024 Authors: Fang P; Noticewala SS; Wu SY; Gunther JR; Ludmir EB; Medeiros LJ; Strati P; Nair R; Nze C; Nastoupil LJ -
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
Blood Volume: 144 Page(s): 2063 - 2066
11/07/2024 Authors: Abro B; Maurer MJ; Habermann TM; Burack WR; Chapman JR; Cohen JB; Friedberg JW; Inghirami G; Kahl BS; Larson MC -
Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial.
Curr Med Res Opin Volume: 40 Page(s): 1863 - 1871
11/01/2024 Authors: Trotman J; Zinzani PL; Song Y; Delarue R; Kim P; Ivanova E; Korde R; Mayer J; De Oliveira AC; Assouline SE -
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
Nat Commun Volume: 15 Page(s): 8668
10/07/2024 Authors: Zhang S; Jiang VC; Han G; Hao D; Lian J; Liu Y; Cai Q; Zhang R; McIntosh J; Wang R -
CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation.
iScience Volume: 27 Page(s): 110830
09/20/2024 Authors: Huang M; Ke Z; Lyu M-A; Masarova L; Sadeghi T; Flowers CR; Parmar S -
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther Volume: 30 Page(s): 832 - 843
09/01/2024 Authors: Iqbal M; Kumar A; Dreger P; Chavez J; Sauter CS; Sureda AM; Bachanova V; Maziarz RT; Dreyling M; Smith SM -
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial.
JAMA Oncol Volume: 10 Page(s): 1195 - 1203
09/01/2024 Authors: Pinnix CC; Dabaja BS; Gunther JR; Fang PQ; Wu SY; Nastoupil LJ; Strati P; Nair R; Ahmed S; Steiner R -
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL.
Blood Adv Volume: 8 Page(s): 4414 - 4422
08/27/2024 Authors: Khurana A; Mwangi R; Nastoupil LJ; Reagan PM; Farooq U; Romancik JT; McDonnell TJ; Riska SM; Lossos LS; Kahl BS -
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase1/2trial.
EClinicalMedicine Volume: 74 Page(s): 102747
08/01/2024 Authors: Gurumurthi A; Chin CK; Feng L; Fowler NH; Strati P; Hagemeister FB; Fayad LE; Westin JR; Obi C; Arafat J -
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL.
Blood Adv Volume: 8 Page(s): 3825 - 3837
07/23/2024 Authors: Nze C; Andersen CR; Ayers AA; Westin J; Wang M; Iyer S; Ahmed S; Pinnix C; Vega F; Nguyen L -
Defining primary refractory large B-cell lymphoma.
Blood Adv Volume: 8 Page(s): 3402 - 3415
07/09/2024 Authors: Bock AM; Mwangi R; Wang Y; Khurana A; Maurer MJ; Ayers A; Kahl BS; Martin P; Cohen JB; Casulo C -
Neighborhood-level social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival.
JNCI Cancer Spectr Volume: 8
07/01/2024 Authors: Rodriguez ER; Tonn T; Jafry M; Ahmed S; Cuglievan B; Livingston JA; Flowers CR; Aune GJ; Albritton KH; Roth ME -
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
Haematologica Volume: 109 Page(s): 2177 - 2185
07/01/2024 Authors: Maurer MJ; Casulo C; Larson MC; Habermann TM; Lossos IS; Wang Y; Nastoupil LJ; Strouse C; Chihara D; Martin P -
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial.
Lancet Haematol Volume: 11 Page(s): e521 - e529
07/01/2024 Authors: Gunther JR; Xu J; Bhutani MS; Strati P; Fang PQ; Wu SY; Dabaja BS; Dong W; Bhosale PR; Flowers CR -
Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study.
Am J Hematol Volume: 99 Page(s): 1230 - 1239
07/01/2024 Authors: Ma S; La J; Swinnerton KN; Guffey D; Bandyo R; De Las Pozas G; Hanzelka K; Xiao X; Rojas-Hernandez CM; Amos CI -
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma.
Am J Hematol Volume: 99 Page(s): 1281 - 1289
07/01/2024 Authors: Yuen S; Phillips TJ; Bannerji R; Marlton P; Gritti G; Seymour JF; Johnston A; Arthur C; Dodero A; Sharma S -
MASH: MEDIATION ANALYSIS OF SURVIVAL OUTCOME AND HIGH-DIMENSIONAL OMICS MEDIATORS WITH APPLICATION TO COMPLEX DISEASES.
Ann Appl Stat Volume: 18 Page(s): 1360 - 1377
06/01/2024 Authors: Chi S; Flowers CR; Li Z; Huang X; Wei P -
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study.
CPT Pharmacometrics Syst Pharmacol Volume: 13 Page(s): 1055 - 1066
06/01/2024 Authors: Deng R; Gibiansky L; Lu T; Flowers CR; Sehn LH; Liu Q; Agarwal P; Liao MZ; Dere R; Lee C -
Cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib.
Blood Adv Volume: 8 Page(s): 2478 - 2490
05/28/2024 Authors: Moslehi JJ; Furman RR; Tam CS; Salem J-E; Flowers CR; Cohen A; Zhang M; Zhang J; Chen L; Ma H -
CASi: A framework for cross-timepoint analysis of single-cell RNA sequencing data.
Sci Rep Volume: 14 Page(s): 10633
05/09/2024 Authors: Wang Y; Flowers CR; Wang M; Huang X; Li Z -
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
Haematologica Volume: 109 Page(s): 1460 - 1468
05/01/2024 Authors: Jallouk AP; Kui N; Sun R; Westin JR; Steiner RE; Nair R; Nastoupil LJ; Fayad LE; Zaki AA; Hawkins M -
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
Leuk Lymphoma Volume: 65 Page(s): 669 - 673
05/01/2024 Authors: Lionel AC; Gurumurthi A; Fetooh A; Eldaya R; Ahmed S; Iyer SP; Nastoupil LJ; Westin J; Nair R; Fayad L -
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study.
Haematologica Volume: 109 Page(s): 1194 - 1205
04/01/2024 Authors: Flowers CR; Matasar MJ; Herrera AF; Hertzberg M; Assouline S; Demeter J; McMillan A; Mehta A; Opat S; Trnn M -
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
Cancer Volume: 130 Page(s): 876 - 885
03/15/2024 Authors: Gordon MJ; Feng L; Strati P; Lee HJ; Hagemeister FB; Westin JR; Samaniego F; Marques-Piubelli ML; Vega Vazquez F; Parra Cuentas ER -
MASH: MEDIATION ANALYSIS OF SURVIVAL OUTCOME AND HIGH-DIMENSIONAL OMICS MEDIATORS WITH APPLICATION TO COMPLEX DISEASES.
bioRxiv
03/07/2024 Authors: Chi S; Flowers CR; Li Z; Huang X; Wei P -
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial.
Nat Med Volume: 30 Page(s): 772 - 784
03/01/2024 Authors: Marin D; Li Y; Basar R; Rafei H; Daher M; Dou J; Mohanty V; Dede M; Nieto Y; Uprety N -
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
Am J Hematol Volume: 99 Page(s): 408 - 421
03/01/2024 Authors: Cerhan JR; Maurer MJ; Link BK; Feldman AL; Habermann TM; Jaye DL; Burack WR; McDonnell TJ; Vega F; Chapman JR -
The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
Exp Hematol Oncol Volume: 13 Page(s): 14
02/07/2024 Authors: Yan F; Jiang V; Jordan A; Che Y; Liu Y; Cai Q; Xue Y; Li Y; McIntosh J; Chen Z -
Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning.
Diagn Pathol Volume: 19 Page(s): 17
01/19/2024 Authors: Tavolara TE; Niazi MKK; Feldman AL; Jaye DL; Flowers C; Cooper LAD; Gurcan MN -
Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes.
Front Transplant Volume: 3 Page(s): 1448650
01/01/2024 Authors: Zeng K; Ma H; Huang M; Lyu M-A; Sadeghi T; Flowers CR; Parmar S -
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.
Br J Haematol Volume: 204 Page(s): e11 - e16
01/01/2024 Authors: Mamlouk O; Strati P; Feng L; Sun R; Ayers A; Steiner RE; Nair R; Flowers C; Ramdial JL; Saini N -
Association of Emotional Exhaustion With Career Burnout Among Early-Career Medical Oncologists: A Single-Institution Study.
JCO Oncol Pract Volume: 20 Page(s): 137 - 144
01/01/2024 Authors: Singh AP; Xiao L; O'Brien BJ; Blondeau CE; Flowers CR; Bruera E; Morris VK; Shah AY -
The impact of a multidisciplinary goals-of-care program on unplanned readmission rates at a comprehensive cancer center.
Support Care Cancer Volume: 32 Page(s): 66
12/27/2023 Authors: Leung C; Andersen CR; Wilson K; Nortje N; George M; Flowers C; Bruera E; Hui D -
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
J Hematol Oncol Volume: 16 Page(s): 122
12/16/2023 Authors: Vose JM; Fu K; Wang L; Mansoor A; Stewart D; Cheng H; Smith L; Yuan J; Qureishi HN; Link BK -
Barriers to accessing cellular therapy for patients receiving care in community practices.
Hematology Am Soc Hematol Educ Program Volume: 2023 Page(s): 382 - 385
12/08/2023 Authors: Nze C; Flowers CR -
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.
J Clin Oncol Volume: 41 Page(s): 5107 - 5117
11/20/2023 Authors: Zinzani PL; Mayer J; Flowers CR; Bijou F; De Oliveira AC; Song Y; Zhang Q; Merli M; Bouabdallah K; Ganly P -
A single-cell atlas of CD19 chimeric antigen receptor Tcells.
Cancer Cell Volume: 41 Page(s): 1835 - 1837
11/13/2023 Authors: Li X; Henderson J; Gordon MJ; Sheikh I; Nastoupil LJ; Westin J; Flowers C; Ahmed S; Wang L; Neelapu SS -
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma.
Blood Cancer J Volume: 13 Page(s): 156
10/12/2023 Authors: Jain P; Nomie K; Kotlov N; Segodin V; Hill H; Ok CY; Fetooh A; Kanagal-Shamanna R; Vega F; Bagaev A -
Prolonged cytopenia following CD19 CAR Tcell therapy is linked with bone marrow infiltration of clonally expanded IFN-expressing CD8 Tcells.
Cell Rep Med Volume: 4 Page(s): 101158
08/15/2023 Authors: Strati P; Li X; Deng Q; Marques-Piubelli ML; Henderson J; Watson G; Deaton L; Cain T; Yang H; Ravanmehr V -
Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy.
Am J Hematol Volume: 98 Page(s): 1214 - 1222
08/01/2023 Authors: Li A; May SB; La J; Martens KL; Amos CI; Flowers CR; Do NV; Brophy MT; Chitalia V; Ravid K -
Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
Cells Volume: 12
07/18/2023 Authors: Zeng K; Huang M; Lyu M-A; Khoury JD; Ahmed S; Patel KK; Dropuli B; Reese-Koc J; Caimi PF; Sadeghi T -
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS.
Blood Adv Volume: 7 Page(s): 3075 - 3079
07/11/2023 Authors: Gladstone DE; D'Alessio F; Howard C; Lyu M-A; Mock JR; Gibbs KW; Abrams D; Huang M; Zeng K; Herlihy JP -
Clinical approaches for integrating machine learning for patients with lymphoma: Current strategies and future perspectives.
Br J Haematol Volume: 202 Page(s): 219 - 229
07/01/2023 Authors: Chihara D; Nastoupil LJ; Flowers CR -
External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center.
Am J Hematol Volume: 98 Page(s): 1052 - 1057
07/01/2023 Authors: Li A; De Las Pozas G; Andersen CR; Nze CC; Toale KM; Milner EM; Fillmore NR; Chiao EY; Rojas Hernandez C; Kroll MH -
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.
Blood Adv Volume: 7 Page(s): 2287 - 2296
06/13/2023 Authors: Epperla N; Switchenko J; Bachanova V; Gerson JN; Barta SK; Gordon MJ; Danilov AV; Grover NS; Mathews S; Burkart M -
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Hematol Oncol Volume: 41 Suppl 2 Page(s): 167 - 168
06/01/2023 Authors: Steiner RE; Strati P; Flowers CR; Neelapu SS; Green M; Nastoupil LJ; Hagemeister FB; Feng L; Ahmed S; Nair R -
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Hematol Oncol Volume: 41 Suppl 2 Page(s): 430 - 432
06/01/2023 Authors: Bock AM; Mwangi R; Wang Y; Khurana A; Maurer MJ; Ayers A; Kahl B; Martin P; Cohen J; Casulo C -
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.
J Clin Oncol Volume: 41 Page(s): 3063 - 3071
06/01/2023 Authors: Key NS; Khorana AA; Kuderer NM; Bohlke K; Lee AYY; Arcelus JI; Wong SL; Balaban EP; Flowers CR; Gates LE -
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.
J Clin Oncol Volume: 41 Page(s): 2926 - 2938
06/01/2023 Authors: Li A; La J; May SB; Guffey D; da Costa WL; Amos CI; Bandyo R; Milner EM; Kurian KM; Chen DCR -
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma.
Blood Volume: 141 Page(s): 1888 - 1893
04/13/2023 Authors: Alderuccio JP; Reis IM; Koff JL; Larson MC; Chihara D; Zhao W; Haddadi S; Habermann TM; Martin P; Chapman JR -
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL.
Blood Adv Volume: 7 Page(s): 1137 - 1145
04/11/2023 Authors: Cherng H-JJ; Alig SK; Oki Y; Nastoupil LJ; Fayad L; Neelapu SS; Turturro F; Hagemeister F; Craig AFM; Macaulay CW -
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response.
Haematologica Volume: 108 Page(s): 1163 - 1167
04/01/2023 Authors: Jallouk AP; Gouni S; Westin J; Feng L; Mistry H; Steiner RE; James J; Noorani M; Horowitz S; Puebla-Osorio N -
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
Nat Med Volume: 29 Page(s): 906 - 916
04/01/2023 Authors: Stein-Thoeringer CK; Saini NY; Zamir E; Blumenberg V; Schubert M-L; Mor U; Fante MA; Schmidt S; Hayase E; Hayase T -
PD-L1+ macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma.
Exp Hematol Oncol Volume: 12 Page(s): 32
03/20/2023 Authors: Steiner RE; Parra ER; Vega F; Feng L; Westin JR; Neelapu SS; Strati P; Green MR; Flowers CR; Solis LM -
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
Am J Hematol Volume: 98 Page(s): 449 - 463
03/01/2023 Authors: Lasater EA; Amin DN; Bannerji R; Mali RS; Barrett K; Rys RN; Oeh J; Lin E; Sterne-Weiler T; Ingalla ER -
Allogeneic cord blood regulatory T cells can resolve lung inflammation.
Cytotherapy Volume: 25 Page(s): 245 - 253
03/01/2023 Authors: Lyu M-A; Huang M; Zeng K; Li L; Khoury JD; Nishimoto M; Ma H; Sadeghi T; Mukherjee S; Slutsky AS -
Differential Impact of a Multicomponent Goals-of-Care Program in Patients with Hematologic and Solid Malignancies.
Cancers (Basel) Volume: 15
02/28/2023 Authors: Hui D; Ahmed S; Nortje N; George M; Andersen CR; Wilson K; Urbauer D; Flowers C; Bruera E -
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
J Clin Oncol Volume: 41 Page(s): 745 - 755
02/01/2023 Authors: Westin J; Davis RE; Feng L; Hagemeister F; Steiner R; Lee HJ; Fayad L; Nastoupil L; Ahmed S; Rodriguez A -
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
J Clin Invest Volume: 133
02/01/2023 Authors: Jiang VC; Liu Y; Lian J; Huang S; Jordan A; Cai Q; Lin R; Yan F; McIntosh J; Li Y -
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis.
J Clin Oncol Volume: 41 Page(s): 579 - 589
01/20/2023 Authors: Hui D; Nortje N; George M; Wilson K; Urbauer DL; Lenz CA; Wallace SK; Andersen CR; Mendoza T; Haque S -
Immune-based therapies in diffuse large B-cell lymphoma.
Expert Opin Investig Drugs Volume: 32 Page(s): 479 - 493
01/01/2023 Authors: McCurry D; Flowers CR; Bermack C -
Impact of multi-agent systemic therapy on all-cause and disease-specific survival for people living with HIV who are diagnosed with non-Hodgkin lymphoma: population-based analyses from the state of Georgia.
Leuk Lymphoma Volume: 64 Page(s): 151 - 160
01/01/2023 Authors: Lipscomb J; Switchenko JM; Flowers CR; Gillespie TW; Wortley PM; Bayakly AR; Almon L; Ward KC -
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Front Immunol Volume: 14 Page(s): 1217121
01/01/2023 Authors: Lyu M-A; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR -
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
Br J Haematol Volume: 200 Page(s): 35 - 44
01/01/2023 Authors: Cherng H-JJ; Xu G; Feng L; Steiner R; Fayad L; Strati P; Nair R; Nastoupil LJ; Lee HJ; Neelapu SS -
Sequencing therapy in relapsed DLBCL.
Hematology Am Soc Hematol Educ Program Volume: 2022 Page(s): 146 - 154
12/09/2022 Authors: Flowers CR; Odejide OO -
BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALS.
Ann Appl Stat Volume: 16 Page(s): 2481 - 2504
12/01/2022 Authors: Lin R; Shi H; Yin G; Thall PF; Yuan Y; Flowers CR -
Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.
Clin Lymphoma Myeloma Leuk Volume: 22 Page(s): e1084 - e1091
12/01/2022 Authors: Romancik JT; Chen Z; Allen PB; Waller EK; Valla K; Colbert A; Rosand C; Palmer AF; Flowers CR; Cohen JB -
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma.
Cell Rep Med Volume: 3 Page(s): 100720
11/15/2022 Authors: Fahrmann JF; Saini NY; Chia-Chi C; Irajizad E; Strati P; Nair R; Fayad LE; Ahmed S; Lee HJ; Iyer S -
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy.
Leukemia Volume: 36 Page(s): 2669 - 2677
11/01/2022 Authors: Strati P; Jallouk AP; Sun R; Choi J; Das K; Cherng H-J; Ahmed S; Lee HJ; Iyer SP; Nair R -
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials.
Clin Lymphoma Myeloma Leuk Volume: 22 Page(s): e1009 - e1018
11/01/2022 Authors: Dixon JG; alayan ; Chihara D; Nielsen T; Dimier N; Zheng J; Wall AK; Salles G; Morschhauser F; Marcus R -
ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study.
Clin Lymphoma Myeloma Leuk Volume: 22 Suppl 2 Page(s): S358 - S359
10/01/2022 Authors: Flowers C; Tilly H; Morschhauser F; Sehn LH; Friedberg JW; Trnn M; Sharman JP; Herbaux C; Burke JM; Matasar M -
ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant.
Clin Lymphoma Myeloma Leuk Volume: 22 Suppl 2 Page(s): S355 - S356
10/01/2022 Authors: Flowers CR; Burke JM; Vukcevic M; Snodgrass S; Saverno K; Lumiqued MAA; Abdulhaq H; Brem E; Evens A; Farooq U -
The Impact of Sequence of Therapy for Older Patients With Follicular Lymphoma: SEER-Medicare Analysis.
Clin Lymphoma Myeloma Leuk Volume: 22 Page(s): e938 - e946
10/01/2022 Authors: Xie C; Li R; Huang X; Chihara D; Flowers CR -
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.
Mol Cancer Volume: 21 Page(s): 185
09/26/2022 Authors: Jiang VC; Hao D; Jain P; Li Y; Cai Q; Yao Y; Nie L; Liu Y; Jin J; Wang W -
Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.
J Clin Invest Volume: 132
09/15/2022 Authors: Chang A; Sholukh AM; Wieland A; Jaye DL; Carrington M; Huang M-L; Xie H; Jerome KR; Roychoudhury P; Greninger AL -
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
Blood Cancer Discov Volume: 3 Page(s): 428 - 443
09/06/2022 Authors: Han G; Deng Q; Marques-Piubelli ML; Dai E; Dang M; Ma MCJ; Li X; Yang H; Henderson J; Kudryashova O -
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma.
Blood Cancer Discov Volume: 3 Page(s): 385 - 393
09/06/2022 Authors: Saini NY; Swoboda DM; Greenbaum U; Ma J; Patel RD; Devashish K; Das K; Tanner MR; Strati P; Nair R -
CondiS web app: imputation of censored lifetimes for machine learning-based survival analysis.
Bioinformatics Volume: 38 Page(s): 4252 - 4254
09/02/2022 Authors: Wang Y; Flowers CR; Li Z; Huang X -
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
Lancet Volume: 400 Page(s): 512 - 521
08/13/2022 Authors: Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP -
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis.
Blood Adv Volume: 6 Page(s): 4413 - 4423
08/09/2022 Authors: Luan D; Fatola T; Toure A; Flowers CR; Link B; Friedberg JW; Cohen JB; Kahl B; Lossos IS; Nastoupil L -
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood Volume: 140 Page(s): 504 - 515
08/04/2022 Authors: Cherng H-JJ; Sun R; Sugg B; Irwin R; Yang H; Le CC; Deng Q; Fayad L; Fowler NH; Parmar S -
Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations.
Am J Hematol Volume: 97 Page(s): 1044 - 1054
08/01/2022 Authors: da Costa WL; Guffey D; Oluyomi A; Bandyo R; Rosales O; Wallace CD; Granada C; Riaz N; Fitzgerald M; Garcia DA -
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.
Cancer Discov Volume: 12 Page(s): 1782 - 1803
07/06/2022 Authors: Leung W; Teater M; Durmaz C; Meydan C; Chivu AG; Chadburn A; Rice EJ; Muley A; Camarillo JM; Arivalagan J -
CondiS: A conditional survival distribution-based method for censored data imputation overcoming the hurdle in machine learning-based survival analysis.
J Biomed Inform Volume: 131 Page(s): 104117
07/01/2022 Authors: Wang Y; Flowers CR; Li Z; Huang X -
SIRP+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab.
Blood Adv Volume: 6 Page(s): 3286 - 3293
06/14/2022 Authors: Marques-Piubelli ML; Parra ER; Feng L; Soto LS; Gallardo M; Gouni S; Samaniego F; Noorani M; Hagemeister FB; Westin JR -
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.
J Clin Oncol Volume: 40 Page(s): 1949 - 1957
06/10/2022 Authors: Chihara D; Huang EP; Finnigan SR; Cordes LM; Skorupan N; Fukuda Y; Rubinstein LV; Ivy SP; Doroshow JH; Nastoupil LJ -
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy.
Blood Adv Volume: 6 Page(s): 2867 - 2871
05/10/2022 Authors: Al Zaki A; Feng L; Watson G; Ahmed SA; Mistry H; Nastoupil LJ; Hawkins M; Nair R; Iyer SP; Lee HJ -
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey.
Blood Adv Volume: 6 Page(s): 2745 - 2756
05/10/2022 Authors: Harkins RA; Patel SP; Lee MJ; Switchenko JM; Ansell SM; Bartlett NL; Blum KA; Cashen AF; Casulo C; Friedberg JW -
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Cancer Epidemiol Biomarkers Prev Volume: 31 Page(s): 1103 - 1110
05/04/2022 Authors: Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; Casabonne D; Cerhan JR; Cozen W; Alarcn G -
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
Blood Adv Volume: 6 Page(s): 2267 - 2274
04/12/2022 Authors: Akin S; Hosing C; Khouri I; Ahmed S; Alousi A; Fowler N; Joseph J; Truxillo J; Ramdial JL; Maadani F -
In-depth analysis of SARS-CoV-2-specific T cells reveals diverse differentiation hierarchies in vaccinated individuals.
JCI Insight Volume: 7
04/08/2022 Authors: Li L; Muftuoglu M; Liang S; Basyal M; Lv J; Akdogan ME; Chen K; Andreeff M; Flowers CR; Parmar S -
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.
Leuk Lymphoma Volume: 63 Page(s): 821 - 833
04/01/2022 Authors: Halwani AS; Panizo C; Isufi I; Herrera AF; Okada CY; Cull EH; Kis B; Chaves JM; Bartlett NL; Ai W -
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
Lancet Haematol Volume: 9 Page(s): e289 - e300
04/01/2022 Authors: Casulo C; Larson MC; Lunde JJ; Habermann TM; Lossos IS; Wang Y; Nastoupil LJ; Strouse C; Chihara D; Martin P -
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood Volume: 139 Page(s): 1684 - 1693
03/17/2022 Authors: Casulo C; Dixon JG; Le-Rademacher J; Hoster E; Hochster HS; Hiddemann W; Marcus R; Kimby E; Herold M; Sebban C -
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Lancet Oncol Volume: 23 Page(s): 406 - 415
03/01/2022 Authors: Wang ML; Jain P; Zhao S; Lee HJ; Nastoupil L; Fayad L; Ok CY; Kanagal-Shamanna R; Hill HA; Yao Y -
PI3K/ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Blood Volume: 139 Page(s): 523 - 537
01/27/2022 Authors: Funk CR; Wang S; Chen KZ; Waller A; Sharma A; Edgar CL; Gupta VA; Chandrakasan S; Zoine JT; Fedanov A -
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med Volume: 386 Page(s): 351 - 363
01/27/2022 Authors: Tilly H; Morschhauser F; Sehn LH; Friedberg JW; Trnn M; Sharman JP; Herbaux C; Burke JM; Matasar M; Rai S -
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data.
Blood Adv Volume: 6 Page(s): 533 - 543
01/25/2022 Authors: Sehn LH; Hertzberg M; Opat S; Herrera AF; Assouline S; Flowers CR; Kim TM; McMillan A; Ozcan M; Safar V -
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.
J Clin Oncol Volume: 40 Page(s): 202 - 212
01/10/2022 Authors: Jain P; Zhao S; Lee HJ; Hill HA; Ok CY; Kanagal-Shamanna R; Hagemeister FB; Fowler N; Fayad L; Yao Y -
A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Leuk Lymphoma Volume: 63 Page(s): 74 - 83
01/01/2022 Authors: Cherng H-JJ; Chuang HH; Steiner R; Fayad L; Strati P; Nair R; Hagemeister F; Nastoupil LJ; Lee HJ; Neelapu SS -
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy.
Blood Adv Volume: 5 Page(s): 5179 - 5189
12/14/2021 Authors: Bond DA; Switchenko JM; Villa D; Maddocks K; Churnetski M; Gerrie AS; Goyal S; Shanmugasundaram K; Calzada O; Kolla B -
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol Volume: 96 Page(s): 1374 - 1384
11/01/2021 Authors: Karmali R; Switchenko JM; Goyal S; Shanmugasundaram K; Churnetski MC; Kolla B; Bachanova V; Gerson JN; Barta SK; Gordon MJ -
Body mass index and survival of patients with lymphoma.
Leuk Lymphoma Volume: 62 Page(s): 2671 - 2678
11/01/2021 Authors: Chihara D; Larson MC; Robinson DP; Thompson CA; Maurer MJ; Casulo C; Pophali P; Link BK; Habermann TM; Feldman AL -
Microfluidic Platform to Transduce Cell Viability to Distinct Flow Pathways for High-Accuracy Sensing.
ACS Sens Volume: 6 Page(s): 3789 - 3799
10/22/2021 Authors: Chrit FE; Raj A; Young KM; Stone NE; Shankles PG; Lokireddy K; Flowers C; Waller EK; Alexeev A; Sulchek T -
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
Leuk Lymphoma Volume: 62 Page(s): 2400 - 2407
10/01/2021 Authors: Al Feghali KA; Fang P; Gule-Monroe M; Milgrom S; Khoury JD; Gunther JR; Sheu T; Nair R; Ahmed S; Steiner R -
Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study.
Haematologica Volume: 106 Page(s): 2774 - 2778
10/01/2021 Authors: Strati P; De Vos S; Ruan J; Maddocks KJ; Flowers CR; Rule S; Patel P; Xu Y; Wei H; Frigault MM -
Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.
Cancer Volume: 127 Page(s): 3390 - 3402
09/15/2021 Authors: Goldman ML; Mao JJ; Strouse CS; Chen W; Rupji M; Chen Z; Maurer MJ; Calzada O; Churnetski M; Flowers CR -
The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma.
Blood Volume: 138 Page(s): 785 - 789
09/02/2021 Authors: Chihara D; Dores GM; Flowers CR; Morton LM -
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol Volume: 107 Page(s): 301 - 310
09/01/2021 Authors: Shanmugasundaram K; Goyal S; Switchenko J; Calzada O; Churnetski MC; Kolla B; Bachanova V; Gerson JN; Barta SK; Gordon MJ -
Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): 36 - 44
09/01/2021 Authors: Hoppe BS; Advani R; Milgrom SA; Bakst RL; Ballas LK; Dabaja BS; Flowers CR; Ha CS; Mansur DB; Metzger ML -
Perceptions of clinical care and research among African-American patients with lymphoma.
Leuk Lymphoma Volume: 62 Page(s): 1860 - 1868
08/01/2021 Authors: Dance KV; Imbody CB; Chen L; McNeill L; Payne JB; Flowers CR -
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.
Blood Adv Volume: 5 Page(s): 2799 - 2806
07/27/2021 Authors: Greenbaum U; Strati P; Saliba RM; Torres J; Rondon G; Nieto Y; Hosing C; Srour SA; Westin J; Fayad LE -
Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey.
Open Forum Infect Dis Volume: 8 Page(s): ofab198
07/01/2021 Authors: Chang A; Ellingson MK; Flowers CR; Bednarczyk RA -
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.
Blood Volume: 137 Page(s): 3272 - 3276
06/10/2021 Authors: Strati P; Ahmed S; Furqan F; Fayad LE; Lee HJ; Iyer SP; Nair R; Nastoupil LJ; Parmar S; Rodriguez MA -
The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy.
Leuk Lymphoma Volume: 62 Page(s): 1361 - 1369
06/01/2021 Authors: Augustyn A; Medeiros LJ; Ludmir EB; Gunther J; Fang P; Li S; Ok CY; Bankston ME; Verma V; Pasalic D -
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
Nat Commun Volume: 12 Page(s): 2877
05/17/2021 Authors: Zhang S; Jiang VC; Han G; Hao D; Lian J; Liu Y; Cai Q; Zhang R; McIntosh J; Wang R -
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma.
Am J Hematol Volume: 96 Page(s): 599 - 605
05/01/2021 Authors: Maurer MJ; Jakobsen LH; Mwangi R; Schmitz N; Farooq U; Flowers CR; de Nully Brown P; Thompson CA; Frederiksen H; Cunningham D -
Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria.
Leuk Lymphoma Volume: 62 Page(s): 1057 - 1065
05/01/2021 Authors: Ballas LK; Metzger ML; Milgrom SA; Advani R; Bakst RL; Dabaja BS; Flowers CR; Ha CS; Hoppe BS; Mansur DB -
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas.
Leuk Lymphoma Volume: 62 Page(s): 1077 - 1087
05/01/2021 Authors: Wagner-Johnston ND; Schuster SJ; deVos S; Salles G; Jurczak WJ; Flowers CR; Viardot A; Flinn IW; Martin P; Xing G -
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.
Am J Hematol Volume: 96 Page(s): E137 - E140
05/01/2021 Authors: Jain P; Kanagal-Shamanna R; Zhang S; Ok CY; Navsaria L; Nastoupil L; Lee HJ; Tang G; Yin CC; Badillo M -
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials.
Blood Adv Volume: 5 Page(s): 1737 - 1745
03/23/2021 Authors: Casulo C; Dixon JG; Ou F-S; Hoster E; Peterson BA; Hochster HS; Brice P; Ladetto M; Hiddemann W; Marcus R -
Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma.
Blood Cancer J Volume: 11 Page(s): 2
01/07/2021 Authors: Merdan S; Subramanian K; Ayer T; Van Weyenbergh J; Chang A; Koff JL; Flowers C -
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy.
Br J Haematol Volume: 192 Page(s): e38 - e42
01/01/2021 Authors: Jain P; Nastoupil L; Westin J; Lee HJ; Navsaria L; Steiner RE; Ahmed S; Moghrabi O; Oriabure O; Chen W -
Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission: an international, multi-centre propensity-score-matched study.
Volume: 191 Page(s): 806 - 815
12/01/2020 Authors: Chin CK; Lim KJ; Lewis K; Jain P; Qing Y; Feng L; Cheah CY; Seymour JF; Ritchie D; Burbury K -
How should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models?
Leuk Lymphoma Volume: 61 Page(s): 3283 - 3286
12/01/2020 Authors: Harkins RA; Flowers CR -
Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma.
Leuk Lymphoma Volume: 61 Page(s): 2985 - 2989
12/01/2020 Authors: Chin CK; Rodriguez MA; Qing Y; Feng L; Samaniego F; Jain P; Noorani M; Fowler NH; Fayad LE; Westin JR -
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.
Blood Adv Volume: 4 Page(s): 5773 - 5784
11/24/2020 Authors: Noy A; de Vos S; Coleman M; Martin P; Flowers CR; Thieblemont C; Morschhauser F; Collins GP; Ma S; Peles S -
Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer.
Oncology (Williston Park) Volume: 34 Page(s): 494 - 499
11/12/2020 Authors: Payne JB; Flowers CR; Allen PB -
Comprehensive Analysis of Factors Predictive for Time to Transformation and Risk of Transformation in Patients (pts) with Mantle Cell Lymphoma
Volume: 136
11/05/2020 Authors: Jain P; Kanagal-Shamanna R; Navsaria L; Ok CY; Hill H; Jung D; Gonzalez GMN; Lee HJ; Nair R; Ahmed S -
Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hypercvad/MTX in Patients (age <= 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial
Volume: 136
11/05/2020 Authors: Wang M; Jain P; Yao Y; Liu Y; Zhao S; Hill H; Moghrabi O; Lee HJ; Samaniego F; Westin J -
Persistent Overall Response on Early PET/CT Scans during Salvage Therapy for Relapsed or Refractory DLBCL Predicts for Disease Specific Survival
Volume: 136
11/05/2020 Authors: Cherng H-JJ; Steiner RE; Fayad L; Strati P; Nair R; Hagemeister FBB; Nastoupil LJ; Lee HJ; Neelapu SS; Flowers C -
Body Mass Index and Survival of Patients with Lymphoma
Volume: 136
11/05/2020 Authors: Chihara D; Larson MC; Robinson DP; Thompson CA; Maurer MJ; Casulo C; Link BK; Habermann TM; Feldman AL; Flowers C -
Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma
Volume: 136
11/05/2020 Authors: Romancik JT; Allen PB; Waller EK; Chen Z; Valla K; Dixon K; Reagan DJ; Colbert AB; Rosand C; Palmer A -
Retrospective Review of Prognostic and Predictors Markers in Newly Diagnosed Angioimmunoblastic T Cell Lymphoma at UT MD Anderson Cancer Center
Volume: 136
11/05/2020 Authors: Srour SA; Xu J; Al-Juhaishi T; Steiner RE; Ensor J; Ahmed S; Parmar S; Strati P; Nastoupil LJ; Nieto Y -
Describing Treatment of Primary Mediastinal Large B Cell Lymphoma Using Rigorously Defined Molecular Classification: A Retrospective Analysis
Volume: 136
11/05/2020 Authors: Casulo C; Strawderman M; Delage R; Faugh T; Maurer MJ; Link BK; Rosenthnal AC; Ramsower C; Burack R; Syrbu S -
Modernizing Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma: Consensus Recommendations Using a Modified Delphi-Method Survey
Volume: 136
11/05/2020 Authors: Harkins RA; Flowers C -
Maintenance Therapy with Ipilimumab Plus Lenalidomide after Autologous Stem Cell Transplantation for Patients with Lymphoma
Volume: 136
11/05/2020 Authors: Khouri IF; Milton DR; Ledesma C; Jabbour E; Bashir Q; Im JS; Fayad L; Lee HJ; Nair R; Nastoupil LJ -
Nonmyeloablative Allogeneic Stem Cell Transplantation with or without Inotuzumab Ozogamicin for Lymphoid Malignancies
Volume: 136
11/05/2020 Authors: Khouri IF; Gruschkus SK; Gulbis A; Ledesma C; Jain N; Kadia TM; Pemmaraju N; Anderlini P; Bashir Q; Daher M -
Management of BTK Inhibitor Associated Adverse Events: Current Practice Trends Among Healthcare Providers and Concordance with Expert Recommendations
Volume: 136
11/05/2020 Authors: Rosenthal K; Abramson JS; Awan FT; Leonard JP; Vose JM; Quill TA; Flowers C -
Autologous Stem Cell Transplantation for Angioimmunoblastic T-Cell Lymphoma
Volume: 136
11/05/2020 Authors: Srour SA; Nieto Y; Iyer SP; Miranda RN; Maadani F; Rondon G; Saini N; Strati P; Daher M; Nair R -
Beyond Mortality: Health-Related Quality of Life in Adolescent and Young Adult Patients with Lymphoma: A Longitudinal Study
Volume: 136
11/05/2020 Authors: Casulo C; Love T; Lu X; Larson MC; Yost KJ; Rosenthal AC; Habermann TM; Link BK; Feldman AL; Slager SL -
SARS-CoV-2 in multiple myeloma: initial observation and management.
Leuk Lymphoma Volume: 61 Page(s): 2763 - 2766
11/01/2020 Authors: Manasanch EE; Mulanovich V; Manzano J-G; Gaeta MS; Becnel M; Kaufman GP; Lee HC; Amini B; Thomas SK; Iyer SP -
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy.
Clin Lymphoma Myeloma Leuk Volume: 20 Page(s): 757 - 767.e3
11/01/2020 Authors: Kudelka MR; Switchenko JM; Lechowicz MJ; Esiashvili N; Flowers CR; Khan MK; Allen PB -
Radiation Therapy for Refractory High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
Volume: 108 Page(s): S168 - S168
11/01/2020 Authors: Liu Y; Augustyn A; Gunther JR; Fang P; Nastoupil L; Ahmed S; Strati P; Nair R; Steiner R; Westin J -
Assessing the Role of Radiation Therapy for Primary Mediastinal Large B-Cell Lymphoma in the Setting of PET Avid Disease after Chemotherapy
Volume: 108 Page(s): S116 - S116
11/01/2020 Authors: Gjyshi O; Boyce-Fappiano D; Gunther JR; Fang P; Nastoupil L; Nair R; Steiner R; Strati P; Ahmed S; Khoury J -
How Much Did We Impact the Risk of Second Malignancies in Patients with Classical Hodgkin Lymphoma by Changing the Treatment Paradigm?
Volume: 108 Page(s): S141 - S142
11/01/2020 Authors: Damron EP; Boyce-Fappiano D; Gunther JR; Pinnix CC; Fang P; Dong W; Lee H; Ahmed S; Strati P; Flowers C -
Prognostic Value of Disease Location in Secondary Central Nervous System Diffuse Large B-Cell Lymphoma
Volume: 108 Page(s): E751 - E752
11/01/2020 Authors: Al Feghali KA; Fang P; Gule-Monroe MK; Khoury J; Gunther JR; Milgrom SA; Sheu T; Nair R; Ahmed S; Steiner R -
Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes.
Cancer Epidemiol Biomarkers Prev Volume: 29 Page(s): 1844 - 1855
10/01/2020 Authors: Moubadder L; McCullough LE; Flowers CR; Koff JL -
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy.
JAMA Netw Open Volume: 3 Page(s): e2013935
09/01/2020 Authors: Pinnix CC; Gunther JR; Fang P; Bankston ME; Milgrom SA; Boyce D; Lee HJ; Nair R; Steiner R; Strati P -
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
CA Cancer J Clin Volume: 70 Page(s): 321 - 346
09/01/2020 Authors: Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih Y-CT; Walter LC -
Stiffness based enrichment of leukemia cells using microfluidics.
APL Bioeng Volume: 4 Page(s): 036101
09/01/2020 Authors: Islam M; Raj A; McFarland B; Brink HM; Ciciliano J; Fay M; Myers DR; Flowers C; Waller EK; Lam W -
Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission.
Clin Lymphoma Myeloma Leuk Volume: 20 Page(s): 533 - 541
08/01/2020 Authors: Glober G; Gunther J; Fang P; Milgrom S; Korivi BR; Jensen CT; Wagner-Bartak NA; Ahmed S; Lee HJ; Nair R -
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.
Cancer Volume: 126 Page(s): 3493 - 3503
08/01/2020 Authors: Lee MJ; Koff JL; Switchenko JM; Jhaney CI; Harkins RA; Patel SP; Dave SS; Flowers CR -
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Blood Adv Volume: 4 Page(s): 2871 - 2883
07/14/2020 Authors: Pinnix CC; Gunther JR; Dabaja BS; Strati P; Fang P; Hawkins MC; Adkins S; Westin J; Ahmed S; Fayad L -
A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma.
Leuk Lymphoma Volume: 61 Page(s): 1555 - 1564
07/01/2020 Authors: Allen PB; Ayers A; Behera M; Evens AM; Flowers C -
Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States.
JCO Glob Oncol Volume: 6 Page(s): 1124 - 1133
07/01/2020 Authors: Sathyanarayanan V; Flowers CR; Iyer SP -
Lenalidomide in follicular lymphoma.
Blood Volume: 135 Page(s): 2133 - 2136
06/11/2020 Authors: Flowers CR; Leonard JP; Fowler NH -
Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials.
Oncology (Williston Park) Volume: 34 Page(s): 216 - 223
06/10/2020 Authors: Williams S; Ayers AA; Hildebrandt MT; McNeill LH; Flowers CR -
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI.
Blood Volume: 135 Page(s): 2041 - 2048
06/04/2020 Authors: Ruppert AS; Dixon JG; Salles G; Wall A; Cunningham D; Poeschel V; Haioun C; Tilly H; Ghesquieres H; Ziepert M -
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Am J Hematol Volume: 95 Page(s): 623 - 629
06/01/2020 Authors: Zhao S; Kanagal-Shamanna R; Navsaria L; Ok CY; Zhang S; Nomie K; Han G; Hao D; Hill HA; Jiang C -
Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors by race/ethnicity in a multiethnic US population
Volume: 29
06/01/2020 Authors: Bolanos R; Hwang A; Aparicio J; Chao C; Qurashi N; Flowers C; Pullarkat S; Conti D; Wang S; Mann K -
Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL.
Leuk Lymphoma Volume: 61 Page(s): 1380 - 1387
06/01/2020 Authors: Strati P; Ahmed MA; Nastoupil LJ; Feng L; Hagemeister FB; Fayad LE; Rodriguez MA; Samaniego F; Wang M; Westin JR -
Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial.
Lancet Haematol Volume: 7 Page(s): e490 - e497
06/01/2020 Authors: Thanarajasingam G; Leonard JP; Witzig TE; Habermann TM; Blum KA; Bartlett NL; Flowers CR; Pitcher BN; Jung S-H; Atherton PJ -
Clinicopathologic features and outcomes of de novo transformed indolent lymphoma.
Volume: 38
05/20/2020 Authors: Chin CK; Cheah C; Jain P; Fowler NH; Fayad L; Westin J; Rodriguez MA; Noorani M; Neelapu SS; Hagemeister FB -
Machine learning prediction of survival in diffuse large B-cell lymphoma based on gene-expression profiling.
Volume: 38
05/20/2020 Authors: Merdan S; Subramanian K; Ayer T; Koff JL; Chang A; Van Weyenbergh J; Flowers C -
MD Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma.
Volume: 38
05/20/2020 Authors: Nair R; Pinnix CC; Gunther JR; Strati P; Westin J; Fayad L; Hagemeister FB; Iyer SP; Nastoupil LJ; Parmar S -
MACHINE LEARNING PREDICTION OF SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA BASED ON GENE-EXPRESSION PROFILING
Volume: 23 Page(s): S23 - S24
05/01/2020 Authors: Merdan S; Subramanian K; Ayer T; Weyenbergh J; Koff J; Flowers CR -
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.
Cancer Volume: 126 Page(s): 1700 - 1707
04/15/2020 Authors: Clough L; Bayakly AR; Ward KC; Khan MK; Chen SC; Lechowicz MJ; Flowers CR; Allen PB; Switchenko JM -
The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites.
Blood Adv Volume: 4 Page(s): 1407 - 1418
04/14/2020 Authors: Mato A; Nabhan C; Lamanna N; Kay NE; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Swern AS; Sullivan K -
Biologic, clinical, and sociodemographic predictors of multi-agent systemic therapy for non-Hodgkin lymphoma in people living with HIV: a population-based investigation in the state of Georgia.
Leuk Lymphoma Volume: 61 Page(s): 896 - 904
04/01/2020 Authors: Lipscomb J; Switchenko JM; Flowers CR; Gillespie TW; Wortley PM; Bayakly AR; Almon L; Fernando R; Ward KC -
Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 20 Page(s): 234 - 243.e10
04/01/2020 Authors: Patel SP; Harkins RA; Lee MJ; Flowers CR; Koff JL -
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.
Blood Adv Volume: 4 Page(s): 1038 - 1050
03/24/2020 Authors: Jain P; Zhang S; Kanagal-Shamanna R; Ok CY; Nomie K; Gonzalez GN; Gonzalez-Pagan O; Hill HA; Lee HJ; Fayad L -
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
Cancer Volume: 126 Page(s): 1235 - 1242
03/15/2020 Authors: Cohen JB; Wei L; Maddocks KJ; Christian B; Heffner LT; Langston AA; Lechowicz MJ; Porcu P; Flowers CR; Devine SM -
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.
J Clin Oncol Volume: 38 Page(s): 496 - 520
02/10/2020 Authors: Key NS; Khorana AA; Kuderer NM; Bohlke K; Lee AYY; Arcelus JI; Wong SL; Balaban EP; Flowers CR; Francis CW -
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
J Clin Oncol Volume: 38 Page(s): 155 - 165
01/10/2020 Authors: Sehn LH; Herrera AF; Flowers CR; Kamdar MK; McMillan A; Hertzberg M; Assouline S; Kim TM; Kim WS; Ozcan M -
Retroperitoneal Follicular Dendritic Cell Sarcoma: A Case Report.
Adv Radiat Oncol Volume: 5 Page(s): 297 - 300
01/01/2020 Authors: Jiang C; Syed YA; Burdette EB; Jaye DL; Flowers CR; Khan MK -
Priorities for Rural Lymphoma Survivors: A Qualitative Study.
Clin Lymphoma Myeloma Leuk Volume: 20 Page(s): 47 - 52.e3
01/01/2020 Authors: Chen L; Payne JB; Dance KV; Imbody CB; Ho CD; Ayers AA; Flowers CR -
Insurance status impacts overall survival in Burkitt lymphoma.
Volume: 60 Page(s): 3225 - 3234
12/01/2019 Authors: Goldstein JS; Switchenko JM; Behera M; Flowers CR; Koff JL -
Cost burden of diffuse large B-cell lymphoma.
Expert Rev Pharmacoecon Outcomes Res Volume: 19 Page(s): 645 - 661
12/01/2019 Authors: Harkins RA; Patel SP; Flowers CR -
Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Blood Volume: 134 Page(s): 1811 - 1820
11/21/2019 Authors: Lunning M; Vose J; Nastoupil L; Fowler N; Burger JA; Wierda WG; Schreeder MT; Siddiqi T; Flowers CR; Cohen JB -
Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies.
Int J Cancer Volume: 145 Page(s): 2647 - 2660
11/15/2019 Authors: Teras LR; Diver WR; Deubler EL; Krewski D; Flowers CR; Switchenko JM; Gapstur SM -
Patient and caregiver perceptions of lymphoma care and research opportunities: A qualitative study.
Cancer Volume: 125 Page(s): 4096 - 4104
11/15/2019 Authors: Payne JB; Dance KV; Farone M; Phan A; Ho CD; Gutierrez M; Chen L; Flowers CR -
The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient.
Oncology (Williston Park) Volume: 33
11/14/2019 Authors: Blanquicett C; Cohen JB; Flowers C; Johnson T -
Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma.
Blood Volume: 134 Page(s): 19
11/13/2019 Authors: Li X; Kositsky R; Reddy A; Love C; Naresh K; Koff JL; Nystrand I; Lepp S; Pasanen A; Karjalainen-Lindsberg M-L -
Consensus and Divergence in Practice Patterns Among Experts and Community Healthcare Providers for the Treatment of Patients with Mantle Cell Lymphoma
Volume: 134
11/13/2019 Authors: Rosenthal KM; Ansell SM; Leonard JP; Vose JM; Wang ML; Quill TA; Obholz KL; Flowers CR -
Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma
Volume: 134
11/13/2019 Authors: Andrie RM; Burke JM; Flowers CR; Fowler NH; Sharman JP; Quill TA; Obholz KL; Flinn IW -
Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)
Volume: 134
11/13/2019 Authors: Maurer MJ; Jakobsen LH; Schmitz N; Farooq U; Flowers CR; Brown PDN; Thompson CA; Frederiksen H; Cunningham D; Jorgensen J -
Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
Volume: 134
11/13/2019 Authors: Cohen JB; Switchenko JM; Shanmugasundaram K; Goyal S; Calzada O; Churnetski MC; Kolla B; Bachanova V; Gerson JN; Barta SK -
The Impact of Pre-Diagnosis Tobacco Use in Mantle Cell Lymphoma
Volume: 134
11/13/2019 Authors: Romancik J; Switchenko JM; Shanmugasundaram K; Goyal S; Calzada O; Churnetski MC; Kolla B; Bachanova V; Gerson JN; Barta SK -
Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
Volume: 134
11/13/2019 Authors: Epperla N; Switchenko JM; Shanmugasundaram K; Goyal S; Calzada O; Churnetski MC; Kolla B; Bachanova V; Gerson JN; Barta SK -
A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
Volume: 134
11/13/2019 Authors: Caglayan C; Dixon J; Wall A; Salles GA; Hoster E; Hiddemann W; Herold M; Morschhauser F; Sebban C; Hagenbeek A -
Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival in Patients with Low Tumor Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab
Volume: 134
11/13/2019 Authors: Friedberg JW; Brady MT; Strawderman M; Kahl BS; Leonard JP; Lossos IS; Flowers CR; Sutamtewagul G; Cohen JB; Peterson DR -
Exploring the Needs and Priorities of Black Patients with Lymphoma: A Qualitative Study
Volume: 134
11/13/2019 Authors: Dance KV; Chen L; Imbody CB; Flowers CR -
The whole-genome landscape of Burkitt lymphoma subtypes.
Blood Volume: 134 Page(s): 1598 - 1607
11/07/2019 Authors: Panea RI; Love CL; Shingleton JR; Reddy A; Bailey JA; Moormann AM; Otieno JA; Ong'echa JM; Oduor CI; Schroeder KMS -
Dual inhibition of PI3Kdelta and PI3Kgamma to enhance mitochondrial mass and ex vivo expansion of central and stem cell memory T cells from CLL patients
Volume: 7
11/06/2019 Authors: Funk C; Wang S; Waller A; Fleischer L; Sharma A; Spencer H; Gupta V; Ravindranathan S; Shanmugam M; Flowers C -
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.
Expert Rev Hematol Volume: 12 Page(s): 959 - 973
11/01/2019 Authors: Harkins RA; Chang A; Patel SP; Lee MJ; Goldstein JS; Merdan S; Flowers CR; Koff JL -
Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): 699 - 708.e5
11/01/2019 Authors: Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE -
Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection.
Clin Cancer Res Volume: 25 Page(s): 6283 - 6294
11/01/2019 Authors: Aleynick M; Svensson-Arvelund J; Flowers CR; Marabelle A; Brody JD -
Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs.
Leuk Lymphoma Volume: 60 Page(s): 2356 - 2364
10/01/2019 Authors: Zackon AYL; Ayers AA; Yeager KA; Somma ML; Friedberg JW; Flowers CR; Nastoupil LJ -
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma.
Volume: 60 Page(s): 2255 - 2263
09/01/2019 Authors: Gopalsamy SN; Rosenthal KM; Ayers AA; Goy A; Leonard JP; Vose JM; Obholz KL; Armitage JO; Flowers CR -
PET-derived tumor metrics predict DLBCL response and progression-free survival.
Volume: 60 Page(s): 1965 - 1971
08/01/2019 Authors: Islam P; Goldstein J; Flowers CR -
Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.
Leuk Lymphoma Volume: 60 Page(s): 1656 - 1667
07/01/2019 Authors: Ritter AJ; Goldstein JS; Ayers AA; Flowers CR -
Examining genetic ancestry in diffuse large B-cell lymphoma (DLBCL)
Volume: 79
07/01/2019 Authors: Lee MJ; Jhaney CI; Flowers CR; Koff JL -
Epstein-Barr virus prevalence in classical Hodgkin lymphoma tumors is explained by histologic subtype, not race/ethnicity in a multiethnic US population
Volume: 79
07/01/2019 Authors: Bolanos R; Hwang A; Chao C; Flowers C; Pullarkat S; Aparicio J; Wang S; Mann K; Bernal-Mizrachi L; Song J -
A population-based multistate model for diffuse large B-cell lymphoma-specific mortality in older patients.
Cancer Volume: 125 Page(s): 1837 - 1847
06/01/2019 Authors: alayan ; Goldstein JS; Ayer T; Rai A; Flowers CR -
Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): e312 - e320
06/01/2019 Authors: Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB -
Impact on survival of surveillance imaging after first remission in follicular lymphoma.
Volume: 37
05/20/2019 Authors: Mao J; Strouse CS; Goldman M; Chen W; Chen Z; Maurer MJ; Calzada O; Churnetski M; Flowers C; Cerhan JR -
Association of geographic clustering of cutaneous T-cell lymphoma in the state of Georgia with environmental exposure to benzene and trichloroethylene
Volume: 37
05/20/2019 Authors: Allen PB; Clough L; Bayakly AR; Ward KC; Khan MK; Chen S; Flowers C; Switchenko JM -
Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.
Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): 300 - 309.e5
05/01/2019 Authors: alayan ; Terawaki H; Ayer T; Goldstein JS; Rai A; Chen Q; Flowers C -
Reply to M.A. Slavin et al.
J Clin Oncol Volume: 37 Page(s): 1140 - 1141
05/01/2019 Authors: Taplitz RA; Kennedy EB; Flowers CR -
Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin.
Volume: 60 Page(s): 940 - 946
04/01/2019 Authors: Badar T; Hamadani M; Bachanova V; Maddocks KJ; Umyarova E; Chavez JC; Epperla N; Chhabra S; Xavier AC; Karmali R -
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
Leuk Lymphoma Volume: 60 Page(s): 894 - 903
04/01/2019 Authors: Sharman JP; Forero-Torres A; Costa LJ; Flinn IW; Inhorn L; Kelly K; Bessudo A; Fayad LE; Kaminski MS; Evens AM -
Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): 239 - 243
04/01/2019 Authors: Chang A; Payne JB; Allen PB; Koff JL; Ahmed R; Flowers CR; Bednarczyk RA -
Updated results from a phase Ib/II study in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) treated with polatuzumab vedotin (pola) plus bendamustine (B) with rituximab (R) or obinutuzumab (G)
Volume: 185 Page(s): 80 - 80
03/01/2019 Authors: McMillan A; Sehn L; Herrera A; Matasar M; Kamdar M; Assouline S; Hertzberg M; Kim TM; Kim WS; Ozcan M -
Epstein-Barr Virus prevalence in classic Hodgkin lymphoma is predicted by histologic subtype and not race or ethnicity a multiethnic US cohort
Volume: 32
03/01/2019 Authors: Bolanos R; Hwang A; Chao C; Flowers C; Pullarkat S; Aparicio J; Wang S; Mann K; Bernal-Mizrachi L; Song J -
Epstein-Barr Virus prevalence in classic Hodgkin lymphoma is predicted by histologic subtype and not race or ethnicity a multiethnic US cohort
Volume: 99
03/01/2019 Authors: Bolanos R; Hwang A; Chao C; Flowers C; Pullarkat S; Aparicio J; Wang S; Mann K; Bernal-Mizrachi L; Song J -
Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma after Autologous Stem Cell Transplantation
Volume: 25
03/01/2019 Authors: Churnetski MC; Switchenko JM; Goyal S; Shanmugasundaram K; Calzada O; Kolla B; Bachanova V; Gerson JN; Barta SK; Maldonado E -
Reply to H.J.A. Adams et al.
J Clin Oncol Volume: 37 Page(s): 526 - 527
02/20/2019 Authors: Shi Q; Flowers CR -
Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial.
Lancet Haematol Volume: 6 Page(s): e100 - e109
02/01/2019 Authors: Nastoupil LJ; Lunning MA; Vose JM; Schreeder MT; Siddiqi T; Flowers CR; Cohen JB; Burger JA; Wierda WG; O'Brien S -
Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System.
Volume: 19 Page(s): 89 - 94
02/01/2019 Authors: Hall KH; Valla K; Flowers CR; Cohen JB -
Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study.
Br J Haematol Volume: 184 Page(s): 660 - 663
02/01/2019 Authors: Link BK; Day B-M; Zhou X; Zelenetz AD; Dawson KL; Cerhan JR; Flowers CR; Friedberg JW -
Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Cancer Volume: 125 Page(s): 185 - 193
01/15/2019 Authors: Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR -
Autograft vs Allograft Comparison in Pediatric Medial Patellofemoral Ligament Reconstruction.
Ochsner J Volume: 19 Page(s): 96 - 101
01/01/2019 Authors: Hendawi T; Godshaw B; Flowers C; Stephens I; Haber L; Waldron S -
Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.
J Oncol Pract Volume: 15 Page(s): 25 - 26
01/01/2019 Authors: Braga CC; Taplitz RA; Flowers CR -
Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic Leukemia.
Cancer J Volume: 25 Page(s): 418 - 427
01/01/2019 Authors: Harkins RA; Patel SP; Flowers CR -
Updated results from a phase Ib/II study in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) treated with polatuzumab vedotin (pola) plus bendamustine (B) with rituximab (R) or obinutuzumab (G)
Volume: 42 Page(s): 3 - 3
01/01/2019 Authors: Glass B; Sehn LH; Herrera AF; Matasar M; Kamdar M; Assouline S; Hertzberg M; Kim TM; Kim WS; McMillan A -
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
Int J Mol Sci Volume: 19
12/19/2018 Authors: Funk CR; Petersen CT; Jagirdar N; Ravindranathan S; Jaye DL; Flowers CR; Langston A; Waller EK -
Microsimulation Modeling in Oncology.
JCO Clin Cancer Inform Volume: 2 Page(s): 1 - 11
12/01/2018 Authors: alayan ; Terawaki H; Chen Q; Rai A; Ayer T; Flowers CR -
Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma.
Leuk Lymphoma Volume: 59 Page(s): 2862 - 2870
12/01/2018 Authors: Calzada O; Switchenko JM; Maly JJ; Blum KA; Grover N; Mathews S; Park SI; Gordon M; Danilov A; Epperla N -
The association of physical activity before and after lymphoma diagnosis with survival outcomes.
Am J Hematol Volume: 93 Page(s): 1543 - 1550
12/01/2018 Authors: Pophali PA; Ip A; Larson MC; Rosenthal AC; Maurer MJ; Flowers CR; Link BK; Farooq U; Feldman AL; Allmer C -
Novel immunotherapy approaches to follicular lymphoma.
Hematology Am Soc Hematol Educ Program Volume: 2018 Page(s): 194 - 199
11/30/2018 Authors: Flowers CR; Leonard JP; Nastoupil LJ -
Sequencing of therapies in relapsed follicular lymphoma.
Hematology Am Soc Hematol Educ Program Volume: 2018 Page(s): 189 - 193
11/30/2018 Authors: Nastoupil LJ; Flowers CR; Leonard JP -
Where to start? Upfront therapy for follicular lymphoma in 2018.
Hematology Am Soc Hematol Educ Program Volume: 2018 Page(s): 185 - 188
11/30/2018 Authors: Leonard JP; Nastoupil LJ; Flowers CR -
Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-kappa B Pathway
Volume: 132
11/29/2018 Authors: Cinar M; Rong H-R; Chineke I; Louissaint A; Chapman-Fredricks JR; Vega F; Gunthel CJ; Love C; Mosunjac M; Flowers CR -
Evaluation of Maintenance Therapy in Cutaneous T-Cell Lymphoma Patients Receiving Total Skin Electron Beam Radiation Therapy
Volume: 132
11/29/2018 Authors: Kudelka M; Lechowicz MJ; Khan MK; Esiashvili N; Flowers CR; Allen P -
The need to assess financial adverse events.
Lancet Haematol Volume: 5 Page(s): e508 - e509
11/01/2018 Authors: Nastoupil LJ; Prasad V; Flowers CR -
In Patients Over 65, Consolidative Radiation for Early Stage Diffuse Large B Cell Lymphoma is Associated with Decreased Hematologic Toxicity and Hospitalizations after RCHOP Compared with RCHOP Alone
Volume: 102 Page(s): S190 - S190
11/01/2018 Authors: Madden NA; Danish H; Cassidy RJ; Abugideiri M; Switchenko J; Rai A; Flowers CR; Esiashvili N; Jegadeesh N; Khan MK -
Consolidative Radiation Therapy (RT) for Advanced Stage Hodgkin's Lymphoma (HL) May Improve Progression Free Survival Than ABVD Alone for Adult Patients.
Volume: 102 Page(s): E280 - E280
11/01/2018 Authors: Subramanian K; Switchenko J; Flowers CR; Esiashvili N; Khan MK -
Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States.
Br J Haematol Volume: 183 Page(s): 385 - 399
11/01/2018 Authors: Blum KA; Keller FG; Castellino S; Phan A; Flowers CR -
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary.
J Oncol Pract Volume: 14 Page(s): 692 - 695
11/01/2018 Authors: Taplitz RA; Kennedy EB; Flowers CR -
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.
J Clin Oncol Volume: 36 Page(s): 3043 - 3054
10/20/2018 Authors: Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston KV -
What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?
J Clin Oncol Page(s): JCO2018793570
10/02/2018 Authors: Flowers CR; Ramsey SD -
Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect CLL cohort study.
Leuk Lymphoma Volume: 59 Page(s): 2327 - 2335
10/01/2018 Authors: Flowers CR; Nabhan C; Kay NE; Mato A; Lamanna N; Farber CM; Davids MS; Kiselev P; Swern AS; Sullivan K -
Disparities in survival by insurance status in follicular lymphoma.
Blood Volume: 132 Page(s): 1159 - 1166
09/13/2018 Authors: Goldstein JS; Nastoupil LJ; Han X; Jemal A; Ward E; Flowers CR -
Reply to J.A. Talcott.
J Clin Oncol Page(s): JCO2018793141
09/04/2018 Authors: Taplitz RA; Kennedy EB; Flowers CR -
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.
Ann Oncol Volume: 29 Page(s): 1932 - 1938
09/01/2018 Authors: de Vos S; Swinnen LJ; Wang D; Reid E; Fowler N; Cordero J; Dunbar M; Enschede SH; Nolan C; Petrich AM -
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 18 Page(s): 569 - 575.e1
09/01/2018 Authors: Yazbeck V; Shafer D; Perkins EB; Coppola D; Sokol L; Richards KL; Shea T; Ruan J; Parekh S; Strair R -
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).
J Clin Oncol Volume: 36 Page(s): 2593 - 2602
09/01/2018 Authors: Shi Q; Schmitz N; Ou F-S; Dixon JG; Cunningham D; Pfreundschuh M; Seymour JF; Jaeger U; Habermann TM; Haioun C -
Identifying and Addressing Disparities in Survival Outcomes for Rural Patients With Cancer.
JAMA Netw Open Volume: 1 Page(s): e181243
08/03/2018 Authors: McCullough LE; Flowers CR -
History of autoimmune conditions and lymphoma prognosis.
Blood Cancer J Volume: 8 Page(s): 73
08/01/2018 Authors: Kleinstern G; Maurer MJ; Liebow M; Habermann TM; Koff JL; Allmer C; Witzig TE; Nowakowski GS; Micallef IN; Johnston PB -
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.
Ann Oncol Volume: 29 Page(s): 1822 - 1827
08/01/2018 Authors: Maurer MJ; Habermann TM; Shi Q; Schmitz N; Cunningham D; Pfreundschuh M; Seymour JF; Jaeger U; Haioun C; Tilly H -
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Cancer Res Volume: 78 Page(s): 4086 - 4096
07/15/2018 Authors: Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J -
Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.
Leuk Lymphoma Volume: 59 Page(s): 1700 - 1709
07/01/2018 Authors: Chen Q; Staton AD; Ayer T; Goldstein DA; Koff JL; Flowers CR -
Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
CA Cancer J Clin Volume: 68 Page(s): 250 - 281
07/01/2018 Authors: Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih Y-CT -
Impact of the posttransplant lymphoproliferative disorder subtype on survival.
Cancer Volume: 124 Page(s): 2327 - 2336
06/01/2018 Authors: Koff JL; Li J-X; Zhang X; Switchenko JM; Flowers CR; Waller EK -
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
Cancer Volume: 124 Page(s): 2306 - 2315
06/01/2018 Authors: Greenwell IB; Staton AD; Lee MJ; Switchenko JM; Saxe DF; Maly JJ; Blum KA; Grover NS; Mathews SP; Gordon MJ -
Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.
Cancer Causes Control Volume: 29 Page(s): 551 - 561
06/01/2018 Authors: Keegan THM; Li Q; Steele A; Alvarez EM; Brunson A; Flowers CR; Glaser SL; Wun T -
Ethnic disparity in primary cutaneous CD30+ T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer database.
Br J Haematol Volume: 181 Page(s): 721 - 722
06/01/2018 Authors: Feldman AL; Flowers CR -
Targeting the B cell receptor pathway in non-Hodgkin lymphoma.
Expert Opin Investig Drugs Volume: 27 Page(s): 513 - 522
06/01/2018 Authors: Valla K; Flowers CR; Koff JL -
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant Volume: 24 Page(s): 1163 - 1171
06/01/2018 Authors: Casulo C; Friedberg JW; Ahn KW; Flowers C; DiGilio A; Smith SM; Ahmed S; Inwards D; Aljurf M; Chen AI -
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.
Oncology (Williston Park) Volume: 32 Page(s): 303 - 309
06/01/2018 Authors: Hall KH; Panjic EH; Valla K; Flowers CR; Cohen JB -
Racial and socioeconomic disparities in mantle cell lymphoma.
Volume: 36
05/20/2018 Authors: Shah N; Liu Y; Xi Y; Flowers C; Koff JL; Behera M; Cohen JB -
Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL).
Volume: 36
05/20/2018 Authors: Ip A; Switchenko JM; Graiser M; Koff JL; Gupta VA; Lechowicz MJ; Nooka AK; Kaufman JL; Lonial S; Waller EK -
ILyAD (Indolent Lymphoma and Vitamin D): A phase III double blind, prospective randomized trial to evaluate the supplemental effect of vitamin D on progression-free survival in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy.
Volume: 36
05/20/2018 Authors: Brady M; Strawderman MS; Flowers C; Kahl BS; Leonard JP; Nastoupil LJ; Witzig TE; Peterson DR; Friedberg JW -
A meta-analysis on ABVD administration in HIV plus patients with advanced stage Hodgkin's lymphoma (HL).
Volume: 36
05/20/2018 Authors: Subramanian K; Switchenko JM; Flowers C; Khan MK -
Outcomes in non-Hodgkin lymphoma by Latino country-of-origin (COO).
Volume: 36
05/20/2018 Authors: Calzada O; Xi Y; Behera M; Koff JL; Flowers C; Liu Y; Cohen JB -
Association of insurance status and race with overall survival among patients with cutaneous T-cell lymphoma: A National Cancer DataBase analysis.
Volume: 36
05/20/2018 Authors: Allen PB; Flowers C; Lechowicz MJ; Goldstein J -
Prevalence and clinical correlates of vulnerable status using the Vulnerable Elders Survey 13 (VES-13) in newly diagnosed adult non-Hodgkin lymphoma (NHL) patients: A LEO cross-sectional analysis.
Volume: 36
05/20/2018 Authors: Fama A; Martin P; Casulo C; Nastoupil LJ; Thompson CA; Link BK; Lossos IS; Kahl B; Maurer M; Allmer C -
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
J Clin Oncol Volume: 36 Page(s): 1443 - 1453
05/10/2018 Authors: Taplitz RA; Kennedy EB; Bow EJ; Crews J; Gleason C; Hawley DK; Langston AA; Nastoupil LJ; Rajotte M; Rolston K -
Effective management strategies for patients with marginal zone lymphoma.
Future Oncol Volume: 14 Page(s): 1213 - 1222
05/01/2018 Authors: Rosand CB; Valla K; Flowers CR; Koff JL -
Balancing patient value and payer cost in hematologic malignancies: can it be done?
Expert Rev Pharmacoecon Outcomes Res Volume: 18 Page(s): 123 - 126
04/01/2018 Authors: Allen PB; Flowers CR -
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update Summary.
J Oncol Pract Volume: 14 Page(s): 250 - 255
04/01/2018 Authors: Taplitz RA; Kennedy EB; Flowers CR -
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.
Leuk Lymphoma Volume: 59 Page(s): 888 - 895
04/01/2018 Authors: Guidot DM; Switchenko JM; Nastoupil LJ; Koff JL; Blum KA; Maly J; Flowers CR; Cohen JB -
Effect of physical activity (PA) before and after diagnosis on overall survival (OS) for patients (pts) with lymphoma.
Volume: 36
03/01/2018 Authors: Ip A; Pophali PA; Larson MC; Rosenthal AC; Maurer MJ; Link BK; Farooq U; Feldman AL; Allmer C; Slager SL -
Lin RJ, Behera M, Diefenbach CS, Flowers CR. Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma. Blood. 2017;130(20):2180-2185.
Blood Volume: 131 Page(s): 1037
03/01/2018 -
Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT)
Volume: 24 Page(s): S135 - S136
03/01/2018 Authors: Ip A; Switchenko JM; Graiser M; Koff J; Gupta V; Lechowicz M; Al-Kadhimi Z; Nooka A; Kaufman J; Lonial S -
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3K inhibitors and VIP antagonists.
Blood Adv Volume: 2 Page(s): 210 - 223
02/13/2018 Authors: Petersen CT; Hassan M; Morris AB; Jeffery J; Lee K; Jagirdar N; Staton AD; Raikar SS; Spencer HT; Sulchek T -
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
Clin Lymphoma Myeloma Leuk Volume: 18 Page(s): 114 - 124.e2
02/01/2018 Authors: Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P -
Characterizing Autoimmune Disease-associated Diffuse Large B-cell Lymphoma in a SEER-Medicare Cohort.
Volume: 18 Page(s): e115 - e121
02/01/2018 Authors: Koff JL; Rai A; Flowers CR -
Informatics Approaches to Address New Challenges in the Classification of Lymphoid Malignancies.
JCO Clin Cancer Inform Volume: 2
01/01/2018 Authors: Jordan J; Goldstein JS; Jaye DL; Gurcan M; Flowers CR; Cooper LAD -
Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome.
Expert Opin Investig Drugs Volume: 27 Page(s): 55 - 70
01/01/2018 Authors: Chang A; Schlafer D; Flowers CR; Allen PB -
When to Choose Transplant in Follicular Lymphoma: Navigating a Complex Landscape.
J Oncol Pract Volume: 13 Page(s): 808 - 809
12/01/2017 Authors: Casulo C; Flowers CR -
The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project.
Oncologist Volume: 22 Page(s): 1415 - 1418
12/01/2017 Authors: Sargent DJ; Shi Q; Flowers CR; Schmitz N; Habermann TM; Flament J; Fu T; Coiffier B; SEAL group -
Early progression of disease as a predictor of survival in chronic lymphocytic leukemia.
Blood Adv Volume: 1 Page(s): 2433 - 2443
11/28/2017 Authors: Ahn IE; Farber CM; Davids MS; Grinblatt DL; Kay NE; Lamanna N; Mato A; Nabhan C; Kiselev P; Swern AS -
Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.
Blood Volume: 130 Page(s): 2180 - 2185
11/16/2017 Authors: Lin RJ; Behera M; Diefenbach CS; Flowers CR -
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.
Cancer Volume: 123 Page(s): 4411 - 4418
11/15/2017 Authors: Epperla N; Maddocks KJ; Salhab M; Chavez JC; Reddy N; Karmali R; Umyarova E; Bachanova V; Costa C; Glenn M -
Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation.
Ann Lymphoma Volume: 1
11/01/2017 Authors: Becnel M; Flowers CR; Nastoupil LJ -
Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
J Clin Oncol Volume: 35 Page(s): 3538 - 3546
11/01/2017 Authors: Leonard JP; Kolibaba KS; Reeves JA; Tulpule A; Flinn IW; Kolevska T; Robles R; Flowers CR; Collins R; DiBella NJ -
Genetic and Functional Drivers of Diffuse Large BCell Lymphoma.
Cell Volume: 171 Page(s): 481 - 494.e15
10/05/2017 Authors: Reddy A; Zhang J; Davis NS; Moffitt AB; Love CL; Waldrop A; Leppa S; Pasanen A; Meriranta L; Karjalainen-Lindsberg M-L -
Reply to . Benedict et al.
J Clin Oncol Volume: 35 Page(s): 3086 - 3087
09/10/2017 Authors: Kohn CG; Zeichner SB; Chen Q; Montero AJ; Goldstein DA; Flowers CR -
Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.
J Clin Oncol Volume: 35 Page(s): 3075 - 3082
09/10/2017 Authors: Polite BN; Adams-Campbell LL; Brawley OW; Bickell N; Carethers JM; Flowers CR; Foti M; Gomez SL; Griggs JJ; Lathan CS -
A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma.
Leuk Lymphoma Volume: 58 Page(s): 1 - 2
09/01/2017 Authors: Cohen JB; Maddocks KJ; Huang Y; Christian BA; Jaglowski SM; Flowers CR; Blum KA -
Unmet needs in the first-line treatment of follicular lymphoma.
Ann Oncol Volume: 28 Page(s): 2094 - 2106
09/01/2017 Authors: Casulo C; Nastoupil L; Fowler NH; Friedberg JW; Flowers CR -
Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?
Cancer Volume: 123 Page(s): 3222 - 3225
09/01/2017 Authors: Koff JL; Flowers CR -
The importance of immunization in cancer prevention, treatment, and survivorship.
CA Cancer J Clin Volume: 67 Page(s): 398 - 410
09/01/2017 Authors: Ward EM; Flowers CR; Gansler T; Omer SB; Bednarczyk RA -
Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.
Cancer Res Volume: 77 Page(s): 4548 - 4555
09/01/2017 Authors: Polite BN; Adams-Campbell LL; Brawley OW; Bickell N; Carethers JM; Flowers CR; Foti M; Gomez SL; Griggs JJ; Lathan CS -
Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.
CA Cancer J Clin Volume: 67 Page(s): 353 - 361
09/01/2017 Authors: Polite BN; Adams-Campbell LL; Brawley OW; Bickell N; Carethers JM; Flowers CR; Foti M; Gomez SL; Griggs JJ; Lathan CS -
Association of Complex Karyotype with Inferior Survival in Mantle Cell Lymphoma is Independent of Specific Cytogenetic Abnormalities
Volume: 17 Page(s): S377 - S377
09/01/2017 Authors: Greenwell IB; Staton AD; Lee M; Switchenko JM; Maly J; Blum K; Grover N; Mathews S; Park S; Gordon M -
American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce.
J Clin Oncol Volume: 35 Page(s): 2576 - 2579
08/01/2017 Authors: Winkfield KM; Flowers CR; Patel JD; Rodriguez G; Robinson P; Agarwal A; Pierce L; Brawley OW; Mitchell EP; Head-Smith KT -
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
Oncogene Volume: 36 Page(s): 4224 - 4232
07/20/2017 Authors: Guo X; Koff JL; Moffitt AB; Cinar M; Ramachandiran S; Chen Z; Switchenko JM; Mosunjac M; Neill SG; Mann KP -
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.
Volume: 23 Page(s): 1117 - 1121
07/01/2017 Authors: Hamilton BK; Rybicki L; Abounader D; Adekola K; Advani A; Aldoss I; Bachanova V; Bashey A; Brown S; DeLima M -
Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
Br J Haematol Volume: 178 Page(s): 72 - 80
07/01/2017 Authors: Tao L; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers CR; Keegan THM -
Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.
Leuk Lymphoma Volume: 58 Page(s): 1570 - 1580
07/01/2017 Authors: Rai A; Nastoupil LJ; Williams JN; Lipscomb J; Ward KC; Howard DH; Lee D; Flowers CR -
CHEMO-FREE TRIPLET COMBINATION OF TGR-1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL
Volume: 102 Page(s): 312 - 312
06/26/2017 Authors: Nastoupil L; Lunning MA; Vose JM; Schreeder MT; Siddiqi T; Flowers CR; Cohen JB; Burger JA; Wierda WG; O'Brien S -
Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.
Infect Control Hosp Epidemiol Volume: 38 Page(s): 651 - 657
06/01/2017 Authors: Shah NN; McClellan W; Flowers CR; Lonial S; Khoury H; Waller EK; Langston A; Nooka AK -
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
Blood Volume: 129 Page(s): 3037 - 3039
06/01/2017 Authors: Gopal AK; Kahl BS; Flowers CR; Martin P; Ansell SM; Abella-Dominicis E; Koh B; Ye W; Barr PM; Salles GA -
Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma.
J Gastrointest Oncol Volume: 8 Page(s): 513 - 523
06/01/2017 Authors: Zeichner SB; Goldstein DA; Kohn C; Flowers CR -
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.
Oncologist Volume: 22 Page(s): 694 - 699
06/01/2017 Authors: Goldstein DA; Chen Q; Ayer T; Chan KKW; Virik K; Hammerman A; Brenner B; Flowers CR; Hall PS -
Reply to C. Nabhan et al.
J Clin Oncol Volume: 35 Page(s): 1864 - 1865
06/01/2017 Authors: Chen Q; Jain N; Flowers CR; Chhatwal J -
A multistate model for follicular lymphoma (FL) patients (pts) who experience early progression.
Volume: 35
05/20/2017 Authors: Terawaki H; Caglayan C; Chen Q; Rai A; Ayer T; Flowers C -
Tolerability and activity of chemo-free triplet combination of TGR-1202, ublituximab, and ibrutinib in patients with advanced CLL and NHL.
Volume: 35
05/20/2017 Authors: Nastoupil LJ; Lunning MA; Vose J; Schreeder MT; Siddiqi T; Flowers C; Cohen JB; Burger JA; Wierda WG; O'Brien SM -
MYC plus relapsed and refractory (R/R) diffuse large b-cell lymphoma (DLBCL): Impact of additional hits and outcomes with subsequent therapy.
Volume: 35
05/20/2017 Authors: Epperla N; Maddocks KJ; Salhab M; Chavez JC; Reddy NM; Karmali R; Umyarova E; Bachanova V; Glenn MJ; Xavier AC -
Interim metabolic tumor volume to predict response in diffuse large B-cell lymphoma.
Volume: 35
05/20/2017 Authors: Islam P; Goldstein J; Sethi I; Lee D; Flowers C -
THE COST-EFFECTIVENESS OF PRECISION MEDICINE TREATMENT STRATEGIES FOR DIFFUSE LARGE B-CELL LYMPHOMA
Volume: 20 Page(s): A107 - A107
05/01/2017 Authors: Chen Q; Staton AD; Ayer T; Goldstein DA; Koff JL; Flowers CR -
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.
Blood Volume: 129 Page(s): 2224 - 2232
04/20/2017 Authors: Noy A; de Vos S; Thieblemont C; Martin P; Flowers CR; Morschhauser F; Collins GP; Ma S; Coleman M; Peles S -
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.
J Clin Oncol Volume: 35 Page(s): 1194 - 1202
04/10/2017 Authors: Kohn CG; Zeichner SB; Chen Q; Montero AJ; Goldstein DA; Flowers CR -
[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
Leuk Lymphoma Volume: 58 Page(s): 809 - 815
04/01/2017 Authors: Wong-Sefidan I; Byrtek M; Zhou X; Friedberg JW; Flowers CR; Zelenetz AD; Dawson KL; Reid E -
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study.
Haematologica Volume: 102 Page(s): e156 - e159
04/01/2017 Authors: Salles G; Schuster SJ; de Vos S; Wagner-Johnston ND; Viardot A; Blum KA; Flowers CR; Jurczak WJ; Flinn IW; Kahl BS -
The Genetic Basis of Hepatosplenic T-cell Lymphoma.
Cancer Discov Volume: 7 Page(s): 369 - 379
04/01/2017 Authors: McKinney M; Moffitt AB; Gaulard P; Travert M; De Leval L; Nicolae A; Raffeld M; Jaffe ES; Pittaluga S; Xi L -
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.
BMC Cancer Volume: 17 Page(s): 198
03/16/2017 Authors: Nabhan C; Mato A; Flowers CR; Grinblatt DL; Lamanna N; Weiss MA; Davids MS; Swern AS; Bhushan S; Sullivan K -
HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy.
Cancer Epidemiol Biomarkers Prev Volume: 26 Page(s): 303 - 311
03/01/2017 Authors: Han X; Jemal A; Hulland E; Simard EP; Nastoupil L; Ward E; Flowers CR -
Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow.
Expert Rev Anticancer Ther Volume: 17 Page(s): 271 - 279
03/01/2017 Authors: Greenwell IB; Flowers CR; Blum KA; Cohen JB -
Outcomes in Mantle Cell Lymphoma for Elderly Patients Undergoing Autologous Stem Cell Transplant in CR1
Volume: 23 Page(s): S215 - S216
03/01/2017 Authors: Greenwell IB; Valla K; Caulfield S; Switchenko JM; Staton A; Flowers C; Maly J; Blum KA; Grover N; Mathews S -
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.
J Clin Oncol Volume: 35 Page(s): 552 - 560
02/10/2017 Authors: Shi Q; Flowers CR; Hiddemann W; Marcus R; Herold M; Hagenbeek A; Kimby E; Hochster H; Vitolo U; Peterson BA -
Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.
Blood Volume: 129 Page(s): 561 - 564
02/02/2017 Authors: Cohen JB; Behera M; Thompson CA; Flowers CR -
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.
Am J Hematol Volume: 92 Page(s): 161 - 170
02/01/2017 Authors: Costa LJ; Maddocks K; Epperla N; Reddy NM; Karmali R; Umyarova E; Bachanova V; Costa C; Glenn MJ; Chavez JC -
Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States.
J Clin Oncol Volume: 35 Page(s): 166 - 174
01/10/2017 Authors: Chen Q; Jain N; Ayer T; Wierda WG; Flowers CR; O'Brien SM; Keating MJ; Kantarjian HM; Chhatwal J -
Making the Case for Improving Oncology Workforce Diversity.
Am Soc Clin Oncol Educ Book Volume: 37 Page(s): 18 - 22
01/01/2017 Authors: Winkfield KM; Flowers CR; Mitchell EP -
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
Bone Marrow Transplant Volume: 52 Page(s): 132 - 134
01/01/2017 Authors: DeFilipp Z; Rosand CB; Goldstein DA; Master VA; Carthon BC; Harris WB; Kucuk O; Al-Kadhimi Z; Cohen JB; Flowers CR -
ACR Appropriateness Criteria Recurrent Hodgkin Lymphoma.
Oncology (Williston Park) Volume: 30 Page(s): 1099 - 1108
12/15/2016 Authors: Winkfield KM; Advani RH; Ballas LK; Dabaja BS; Dhakal S; Flowers CR; Ha CS; Hoppe BS; Mansur DB; Mendenhall NP -
Early Progression of Disease (< 2 Years) Is a Negative Predictor of Survival in Patients (Pts) with Chronic Lymphocytic Leukemia (CLL): An Analysis from the Connect (R) CLL Registry
Volume: 128
12/02/2016 Authors: Ahn IE; Farber CM; Davids M; Grinblatt DL; Lamanna N; Mato AR; Nabhan C; Kiselev P; Swern AS; Flick ED -
Prolonged Progression-Free Survival Is Possible in Patients with Diffuse Large B-Cell Lymphoma Receiving > 1 Salvage Therapies before Autologous Stem Cell Transplant
Volume: 128
12/02/2016 Authors: Kettle AG; Switchenko J; Calzada O; Anh TP; Farone M; Graiser M; Flowers CR; Cohen JB -
Characteristics of Patients (Pts) with Chronic Lymphocytic Leukemia (CLL) Receiving Rituximab Monotherapy in the Connect (R) CLL Registry
Volume: 128
12/02/2016 Authors: Sharman J; Davids M; Farber CM; Grinblatt DL; Kay NE; Lamanna N; Mato AR; Nabhan C; Sullivan K; Flick ED -
Assessing the Feasibility of Pathology Informatics Approaches for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)
Volume: 128
12/02/2016 Authors: Lewis SJ; Goldstein J; Farone M; Anh TP; Koff JL; Staton AD; Mobadersany P; Cooper L; Flowers C -
CD30 Expression Is Not Acquired at Time of Relapse in Diffuse Large B-Cell Lymphoma
Volume: 128
12/02/2016 Authors: Calzada O; Bradley KT; Switchenko J; Staton AD; Koff JL; Flowers CR; Cohen JB -
An Evaluation of the Role of Surveillance Imaging in Mantle Cell Lymphoma in First Remission
Volume: 128
12/02/2016 Authors: Guidot DM; Switchenko J; Nastoupil LJ; Koff JL; Flowers C; Cohen JB -
Risk Stratification of Untreated Mantle Cell Lymphoma Patients Using MIPI, Ki67 Proliferative Index and Cytogenetics
Volume: 128
12/02/2016 Authors: Staton AD; Greenwell IB; Switchenko JM; Maly J; Blum K; Grover NS; Mathews S; Park SI; Gordon MJ; Danilov AV -
a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)
Volume: 128
12/02/2016 Authors: Maddocks KJ; Cohen JB; Huang Y; Christian BA; Benson DM; Jones J; Flowers C; Heffner LT; Jenkins C; Sexton J -
Primary Failure Diffuse Large B Cell Lymphoma: Early Autologous or Donor Hematopoietic Cell Transplantation Not Effective in Patients with Ultra-High Risk Features
Volume: 128
12/02/2016 Authors: Costa LJ; Reddy N; Maddocks KJ; Epperla N; Karmali R; Bachanova V; Umyarova E; Zhou Z; Glenn M; Chavez JC -
Outcomes for Elderly Patients (pts) with Follicular Lymphoma (FL) Using Individual Patient Data (IPD) from 5922 Pts in 18 Randomized Controlled Trials (RCTs): a Follicular Lymphoma Analysis of Surrogate Hypothesis (FLASH) Group Study
Volume: 128
12/02/2016 Authors: Flowers C; Ou F-S; Shi Q; Hoster E; Peterson BA; Hochster HS; Brice P; Ladetto M; Hiddemann W; Marcus RE -
Sociodemographic Factors Predict Medical Conditions Among Five-Year Survivors of Adolescent and Young Adult Hodgkin Lymphoma
Volume: 128
12/02/2016 Authors: Keegan T; Li Q; Steele A; Alvarez E; Brunson AM; Flowers C; Glaser SL; Wun T -
Assessing the Feasibility of Pathology Informatics Approaches for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)
Volume: 128
12/02/2016 Authors: Lewis SJ; Goldstein J; Farone M; Anh TP; Koff JL; Staton AD; Mobadersany P; Cooper L; Flowers C -
Real-world clinical experience in the Connect chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.
Br J Haematol Volume: 175 Page(s): 892 - 903
12/01/2016 Authors: Mato A; Nabhan C; Kay NE; Weiss MA; Lamanna N; Kipps TJ; Grinblatt DL; Flinn IW; Kozloff MF; Flowers CR -
ACR Appropriateness Criteria Hodgkin Lymphoma-Favorable Prognosis Stage I and II.
Am J Clin Oncol Volume: 39 Page(s): 535 - 544
12/01/2016 Authors: Dhakal S; Advani R; Ballas LK; Dabaja BS; Flowers CR; Ha CS; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP -
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Szary syndrome.
Leuk Lymphoma Volume: 57 Page(s): 2813 - 2819
12/01/2016 Authors: Danish HH; Liu S; Jhaveri J; Flowers CR; Lechowicz MJ; Esiashvili N; Khan MK -
2016 US lymphoid malignancy statistics by World Health Organization subtypes.
CA Cancer J Clin Volume: 66 Page(s): 443 - 459
11/12/2016 Authors: Teras LR; DeSantis CE; Cerhan JR; Morton LM; Jemal A; Flowers CR -
Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update.
Immunotherapy Volume: 8 Page(s): 1335 - 1346
11/01/2016 Authors: Marron TU; Ronner L; Martin PE; Flowers CR; Brody JD -
Consolidative Radiation for Early-Stage Diffuse Large B Cell Lymphoma After CHOP or RCHOP: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis
Volume: 96 Page(s): E499 - E499
10/01/2016 Authors: Danish H; Cassidy RJ; Switchenko JM; Rai A; Jegadeesh N; Flowers CR; Esiashvili N; Khan MK -
Validation of Cutaneous Lymphoma International Prognostic Index (CLIPI) for Mycosis Fungoides and Sezary Syndrome
Volume: 96 Page(s): S165 - S166
10/01/2016 Authors: Jhaveri J; Danish H; Liu S; Flowers CR; Lechwoicz MJ; Patel K; Esiashvili N; Khan MK -
Consolidative Radiation for Early-Stage Diffuse Large B Cell Lymphoma After CHOP or RCHOP: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis
Volume: 96 Page(s): E499 - E499
10/01/2016 Authors: Danish H; Cassidy RJ; Switchenko JM; Rai A; Jegadeesh N; Flowers CR; Esiashvili N; Khan MK -
Validation of Cutaneous Lymphoma International Prognostic Index (CLIPI) for Mycosis Fungoides and Sezary Syndrome
Volume: 96 Page(s): S165 - S166
10/01/2016 Authors: Jhaveri J; Danish H; Liu S; Flowers CR; Lechwoicz MJ; Patel K; Esiashvili N; Khan MK -
Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence.
South Med J Volume: 109 Page(s): 606 - 614
10/01/2016 Authors: Bulka C; Nastoupil LJ; Koff JL; Bernal-Mizrachi L; Ward KC; Williams JN; Bayakly AR; Switchenko JM; Waller LA; Flowers CR -
Consolidative Radiation for Early-Stage Diffuse Large B Cell Lymphoma After CHOP or RCHOP: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E499
10/01/2016 Authors: Danish H; Cassidy RJ; Switchenko JM; Rai A; Jegadeesh N; Flowers CR; Esiashvili N; Khan MK -
Validation of Cutaneous Lymphoma International Prognostic Index (CLIPI) for Mycosis Fungoides and Sezary Syndrome.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): S165 - S166
10/01/2016 Authors: Jhaveri J; Danish H; Liu S; Flowers CR; Lechwoicz MJ; Patel K; Esiashvili N; Khan MK -
The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era.
Leuk Lymphoma Volume: 57 Page(s): 1876 - 1882
08/01/2016 Authors: Cassidy RJ; Jegadeesh N; Switchenko J; Danish H; Esiashvili N; Flowers CR; Khan MK -
Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
Volume: 122 Page(s): 2356 - 2363
08/01/2016 Authors: Cohen JB; Han X; Jemal A; Ward EM; Flowers CR -
ACR Appropriateness Criteria Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.
Am J Clin Oncol Volume: 39 Page(s): 384 - 395
08/01/2016 Authors: Roberts KB; Younes A; Hodgson DC; Advani R; Dabaja BS; Dhakal S; Flowers CR; Ha CS; Hoppe BS; Mendenhall NP -
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
Clin Lymphoma Myeloma Leuk Volume: 16 Page(s): 466 - 471.e1
08/01/2016 Authors: DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R -
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States.
Am J Hematol Volume: 91 Page(s): 770 - 775
08/01/2016 Authors: Nabhan C; Zhou X; Day B-M; Dawson K; Zelenetz AD; Friedberg JW; Cerhan JR; Link BK; Flowers CR -
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Biol Blood Marrow Transplant Volume: 22 Page(s): 1197 - 1205
07/01/2016 Authors: Flowers CR; Costa LJ; Pasquini MC; Le-Rademacher J; Lill M; Shore TB; Vaughan W; Craig M; Freytes CO; Shea TC -
Successful Robotic Excision and Early Chemotherapy for Primary Cardiac Lymphoma.
Ann Thorac Surg Volume: 102 Page(s): 304 - 305
07/01/2016 Authors: Moss E; Goldstein DA; Bradley KT; Flowers CR; Murphy DA -
LONG-TERM FOLLOW-UP OF THE NEXT GENERATION PI3K-DELTA INHIBITOR TGR-1202 DEMONSTRATES SAFETY AND HIGH RESPONSE RATES IN CLL: INTEGRATED-ANALYSIS OF TGR-1202 MONOTHERAPY AND COMBINED WITH UBLITUXIMAB
Volume: 101 Page(s): 50 - 51
06/01/2016 Authors: Mato A; Burris HA; Flinn I; Lunning M; Vose J; Fowler N; Nastoupil L; O'Brien S; Schreeder MT; Patel MR -
LONG-TERM FOLLOW-UP OF THE NEXT GENERATION PI3K-DELTA INHIBITOR TGR-1202 DEMONSTRATES SAFETY AND HIGH RESPONSE RATES IN NHL: INTEGRATED-ANALYSIS OF TGR-1202 MONOTHERAPY AND COMBINED WITH UBLITUXIMAB
Volume: 101 Page(s): 102 - 103
06/01/2016 Authors: O'Connor OA; Flinn I; Lunning M; Vose J; Fowler N; Nastoupil L; O'Brien S; Schreeder MT; Patel MR; Fenske TS -
CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation.
Dermatol Ther (Heidelb) Volume: 6 Page(s): 251 - 263
06/01/2016 Authors: Danish HH; Heumann TR; Bradley KT; Switchenko J; Esiashvili N; Lechowicz MJ; Flowers CR; Khan MK -
B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune disease.
Expert Rev Hematol Volume: 9 Page(s): 553 - 561
06/01/2016 Authors: Koff JL; Flowers CR -
Subsequent primary malignancies (SPMs) after diffuse large B-cell lymphoma (DLBCL) in the modern treatment era.
Volume: 34
05/20/2016 Authors: Keegan THM; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers C; Tao L -
Comparing the cost-effectiveness of immunotherapy strategies in BRAF wild-type advanced melanoma
Volume: 34
05/20/2016 Authors: Zeichner SB; Kohn C; Chen Q; Goldstein DA; Montero AJ; Flowers C -
Deferred treatment as a viable option for selected patients with mantle cell lymphoma.
Volume: 34
05/20/2016 Authors: Calzada O; Switchenko JM; Maly JJ; Blum KA; Grover NS; Mathews S; Park SI; Gordon MJ; Danilov AV; Flowers C -
Association of complex karyotype with inferior progression-free and overall survival in mantle cell lymphoma.
Volume: 34
05/20/2016 Authors: Greenwell IB; Staton AD; Lee MJ; Switchenko JM; Maly JJ; Blum KA; Grover NS; Mathews S; Park SI; Gordon M -
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer.
Med Oncol Volume: 33 Page(s): 48
05/01/2016 Authors: Goldstein DA; Krishna K; Flowers CR; El-Rayes BF; Bekaii-Saab T; Noonan AM -
GIFT4 fusokine converts leukemic B cells into immune helper cells.
J Transl Med Volume: 14 Page(s): 106
04/27/2016 Authors: Deng J; Pennati A; Cohen JB; Wu Y; Ng S; Wu JH; Flowers CR; Galipeau J -
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.
Hum Mol Genet Volume: 25 Page(s): 1663 - 1676
04/15/2016 Authors: Machiela MJ; Lan Q; Slager SL; Vermeulen RCH; Teras LR; Camp NJ; Cerhan JR; Spinelli JJ; Wang SS; Nieters A -
Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma.
Cancer Epidemiol Volume: 41 Page(s): 139 - 151
04/01/2016 Authors: Switchenko JM; Bulka C; Ward K; Koff JL; Bayakly AR; Ryan PB; Waller LA; Flowers CR -
Activity of idelalisib in high-risk follicular lymphoma with early relapse following front line immunochemotherapy
Volume: 173 Page(s): 93 - 93
04/01/2016 Authors: Gopal A; Kahl B; Flowers C; Martin P; Link B; Ansell S; Ye W; Koh B; Abella S; Barr P -
Idelalisib monotherapy results in durable responses in patients with relapsed or refractory Waldenstrom's macroglobulinemia (WM)
Volume: 173 Page(s): 102 - 102
04/01/2016 Authors: Coutre S; Leonard J; Flowers C; Davies A; Jurczak W; Byrd J; Spurgeon S; Peterman S; Holes L; Cho Y -
Idelalisib efficacy and safety in follicular lymphoma patients from a phase 2 study
Volume: 173 Page(s): 100 - 100
04/01/2016 Authors: Zinzani PL; Salles G; Schuster S; de Vos S; Wagner-Johnston N; Viardot A; Flowers C; Will M; Breuleux M; Godfrey W -
Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
Discov Med Volume: 21 Page(s): 181 - 188
03/01/2016 Authors: Glass S; Phan A; Williams JN; Flowers CR; Koff JL -
Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies.
Clin Colorectal Cancer Volume: 15 Page(s): 1 - 6
03/01/2016 Authors: Goldstein DA; Zeichner SB; Bartnik CM; Neustadter E; Flowers CR -
Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
Br J Haematol Volume: 172 Page(s): 724 - 734
03/01/2016 Authors: Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Zhou X; Taylor M; Friedberg JW; Link BK; Cerhan JR; Dawson K -
Perspectives in Oncology Drug Pricing-Reply.
JAMA Oncol Volume: 2 Page(s): 402 - 403
03/01/2016 Authors: Goldstein DA; Howard DH; Flowers CR -
Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.
Cancer Epidemiol Biomarkers Prev Volume: 25 Page(s): 264 - 273
02/01/2016 Authors: Keegan THM; DeRouen MC; Parsons HM; Clarke CA; Goldberg D; Flowers CR; Glaser SL -
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Volume: 54 Page(s): 11 - 17
02/01/2016 Authors: Flinn IW; Bartlett NL; Blum KA; Ardeshna KM; LaCasce AS; Flowers CR; Shustov AR; Thress KS; Mitchell P; Zheng F -
Identifying risk factors for B-cell lymphoma.
Blood Volume: 127 Page(s): 10 - 11
01/07/2016 Authors: Flowers CR; Skibola CF -
Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital.
J Stem Cell Res Ther Volume: 6
01/01/2016 Authors: Yun HD; Dossul T; Bernal-Mizrachi L; Switchenko J; Ndibe C; Ibraheem A; Dixon MD; Langston AA; Nooka AK; Flowers CR -
Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma.
Leuk Lymphoma Volume: 57 Page(s): 842 - 851
01/01/2016 Authors: Chen Q; Ayer T; Nastoupil LJ; Koff JL; Staton AD; Chhatwal J; Flowers CR -
Ublituximab + TGR-1202 Demonstrates Activity and a Favorable Safety Profile in Relapsed/Refractory B-Cell NHL and High-Risk CLL: Phase I Results
Volume: 126
12/03/2015 Authors: Lunning MA; Vose J; Fowler N; Nastoupil L; Burger JA; Wierda W; Schreeder MT; Siddiqi T; Flowers C; Cohen JB -
A Dose-Escalation Study of Venetoclax (ABT-199/GDC-0199) in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma
Volume: 126
12/03/2015 Authors: de Vos S; Swinnen L; Kozloff M; Wang D; Reid E; Nastoupil L; Fowler N; Cordero J; D'Amico D; Diehl S -
A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
Volume: 126
12/03/2015 Authors: Cohen JB; Wei L; Maddocks KJ; Heffner LT; Langston A; Flowers C; Devine SM; Blum KA -
Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant
Volume: 126
12/03/2015 Authors: Lee MJ; Switchenko J; Thomas JS; Koff JL; Nastoupil L; Lechowicz MJ; Langston AA; Flowers C; Cohen JB -
Suvmax in 18-Fluorodeoxyglucose PET/CT Potentially Predict the Estimation of a Positive Biopsy in Cases of Lymphoma
Volume: 126
12/03/2015 Authors: Chandra P; Akinbobuyi O; Liao A; Arora J; Chen Z; Lechowicz MJ; Langston AA; Kowalsky J; Cohen JB; Flowers CR -
Analysis of Early Mortality of Chronic Lymphocytic Leukemia (CLL) Patients Treated in US Practices in the Connect CLL (R) Registry
Volume: 126
12/03/2015 Authors: Farber CM; Mato A; Nabhan C; Kipps TJ; Flowers C; Kay NE; Lamanna N; Grinblatt DL; Kozloff M; Weiss M -
Treatment Selection and Practice Patterns for the Management of High-Risk Chronic Lymphocytic Leukemia (CLL) in the US: An Analysis of the Impact of Risk Stratification on Treatment Selection from the Connect CLL (R) Registry
Volume: 126
12/03/2015 Authors: Mato A; Nabhan C; Flowers C; Kay NE; Kipps TJ; Grinblatt DL; Lamanna N; Kozloff M; Sullivan K; Flick ED -
Activity of Idelalisib in High-Risk Follicular Lymphoma with Early Relapse Following Front Line Immunochemotherapy
Volume: 126
12/03/2015 Authors: Gopal AK; Kahl BS; Flowers C; Martin P; Link BK; Ansell S; Ye W; Koh B; Abella S; Barr PM -
Reasons for Initiation of First-Line Therapy and Early Outcomes for Patients (Pts) with Rai 0/1 Chronic Lymphocytic Leukemia (CLL): An Analysis of the Connect CLL (R) Cohort Study
Volume: 126
12/03/2015 Authors: Flowers C; Nabhan C; Kay NE; Mato A; Lamanna N; Grinblatt DL; Kipps TJ; Kozloff M; Sullivan K; Flick ED -
Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost.
Volume: 1 Page(s): 1293 - 1300
12/01/2015 Authors: Goldstein DA; Chen Q; Ayer T; Howard DH; Lipscomb J; Ramalingam SS; Khuri FR; Flowers CR -
ACR Appropriateness Criteria Diffuse Large B-Cell Lymphoma.
Am J Clin Oncol Volume: 38 Page(s): 610 - 620
12/01/2015 Authors: Dabaja BS; Advani R; Hodgson DC; Dhakal S; Flowers CR; Ha CS; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP -
Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al.
J Clin Oncol Volume: 33 Page(s): 3842 - 3843
11/10/2015 Authors: Goldstein DA; El-Rayes BF; Chen Q; Flowers CR -
Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.
Volume: 33 Page(s): 3727 - 3732
11/10/2015 Authors: Goldstein DA; Ahmad BB; Chen Q; Ayer T; Howard DH; Lipscomb J; El-Rayes BF; Flowers CR -
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study.
Volume: 26 Page(s): 2311 - 2317
11/01/2015 Authors: Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD -
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
Volume: 171 Page(s): 539 - 546
11/01/2015 Authors: Cohen JB; Switchenko JM; Koff JL; Sinha R; Kaufman JL; Khoury HJ; Bumpers N; Colbert A; Hutchison-Rzepka A; Nastoupil LJ -
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk Volume: 15 Page(s): 694 - 698
11/01/2015 Authors: Flowers CR; Brown JR; Rosenthal H; Stock W; Katzen HI; Cohen JB; Sinha R; Lakhanpal S; Leis JF; Waller EK -
Cutaneous CD30+Mycosis Fungoides: Response to Rotational Total Skin Electron Irradiation
Volume: 93 Page(s): E452 - E452
11/01/2015 Authors: Heumann TR; Danish H; Switchenko J; Esiashvili N; Lechwoicz MJ; Flowers CR; Khan MK -
The Role of Consolidative Radiation Therapy for Patients Over Age 60 With Diffuse Large B Cell Lymphoma (DLBCL)
Volume: 93 Page(s): S82 - S82
11/01/2015 Authors: Cassidy RJ; Switchenko J; Jegadeesh N; Rajpara RS; Esiashvili N; Flowers CR; Khan MK -
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
JAMA Volume: 314 Page(s): 1599 - 1614
10/20/2015 Authors: Oeffinger KC; Fontham ETH; Etzioni R; Herzig A; Michaelson JS; Shih Y-CT; Walter LC; Church TR; Flowers CR; LaMonte SJ -
Reply to Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma.
Cancer Volume: 121 Page(s): 3748
10/15/2015 Authors: Williams JN; Koff JL; Flowers CR -
Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy.
BMJ Open Volume: 5 Page(s): e008350
10/06/2015 Authors: Hung OY; Brown JR; Dai T; Easley KA; Flowers CR; Parashar S -
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial.
Transfusion Volume: 55 Page(s): 2351 - 2357
10/01/2015 Authors: Jagirdar N; Harvey RD; Nooka A; Flowers C; Kaufman J; Lonial S; Lechowicz MJ; Langston A; Lipscomb C; Gaylor C -
IDELALISIB EFFICACY AND SAFETY IN FOLLICULAR LYMPHOMA PATIENTS FROM A PHASE 2 STUDY
Volume: 100 Page(s): 17 - 18
10/01/2015 Authors: Zinzani PL; Ghia P; Salles G; Schuster SJ; de Vos S; Wagner-Johnston ND; Viardot A; Flowers CR; Will M; Breuleux M -
IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM MACROGLOBULINEMIA
Volume: 100 Page(s): 38 - 39
10/01/2015 Authors: Zinzani PL; Ghia P; Coutre S; Leonard J; Flowers C; Davies A; Jurczak W; Byrd JC; Spurgeon S; Peterman S -
Identifying racial differences in nodular lymphocyte-predominant Hodgkin lymphoma.
Cancer Volume: 121 Page(s): 3387 - 3389
10/01/2015 Authors: Flowers CR; Nastoupil LJ -
To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.
Curr Hematol Malig Rep Volume: 10 Page(s): 244 - 255
09/01/2015 Authors: Koff JL; Chihara D; Phan A; Nastoupil LJ; Williams JN; Flowers CR -
GIFT4-reprogrammed leukemic B cells for CLL immunotherapy.
Volume: 21
09/01/2015 Authors: Deng J; Cohen J; Pennati A; Wu Y; Yuan S; Flowers C; Galipeau J -
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 15 Page(s): 514 - 518
09/01/2015 Authors: Cohen JB; Bucur S; Winton EF; Sinha R; Heffner LT; King N; Lonial S; Langston AA; Waller EK; Hutchison-Rzepka A -
Reply to age-related differences in quality of life among patients with diffuse large B-cell lymphoma.
Cancer Volume: 121 Page(s): 2858 - 2859
08/15/2015 Authors: Williams JN; Rai A; Flowers CR -
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).
Blood Volume: 126 Page(s): 851 - 857
08/13/2015 Authors: Wagner-Johnston ND; Link BK; Byrtek M; Dawson KL; Hainsworth J; Flowers CR; Friedberg JW; Bartlett NL -
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
J Clin Oncol Volume: 33 Page(s): 2516 - 2522
08/10/2015 Authors: Casulo C; Byrtek M; Dawson KL; Zhou X; Farber CM; Flowers CR; Hainsworth JD; Maurer MJ; Cerhan JR; Link BK -
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.
J Clin Oncol Volume: 33 Page(s): 2399 - 2404
07/20/2015 Authors: Barr PM; Li H; Spier C; Mahadevan D; LeBlanc M; Ul Haq M; Huber BD; Flowers CR; Wagner-Johnston ND; Horwitz SM -
A Plethora of Novel Therapies--Which One to Choose?
Oncology (Williston Park) Volume: 29 Page(s): 499 - 500
07/01/2015 Authors: Cohen JB; Flowers CR -
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.
Br J Haematol Volume: 170 Page(s): 85 - 95
07/01/2015 Authors: Nabhan C; Byrtek M; Rai A; Dawson K; Zhou X; Link BK; Friedberg JW; Zelenetz AD; Maurer MJ; Cerhan JR -
Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
Cancer Volume: 121 Page(s): 1800 - 1808
06/01/2015 Authors: Williams JN; Rai A; Lipscomb J; Koff JL; Nastoupil LJ; Flowers CR -
A DOSE-ESCALATION STUDY OF THE BCL-2 INHIBITOR VENETOCLAX (ABT-199/GDC-0199) PLUS BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON-HODGKIN'S LYMPHOMA (NHL)
Volume: 100 Page(s): 4 - 5
06/01/2015 Authors: de Vos S; Flowers C; Wang D; Swinnen L; Fowler N; Reid E; Cordero J; Gifford M; D'Amico D; Dunbar M -
IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM'S MACROGLOBULINEMIA (WM)
Volume: 100 Page(s): 273 - 273
06/01/2015 Authors: Coutre S; Leonard J; Flowers C; Davies A; Jurczak W; Byrd J; Spurgeon S; Peterman S; Holes L; Cho Y -
PROSPECTIVELY DEFINED TRIAL-(N=13) AND PATIENT-(N=3837) LEVEL ANALYSIS OF COMPLETE RESPONSE RATES AS SURROGATE END-POINTS FOR PROGRESSION-FREE SURVIVAL (PFS) IN FIRST-LINE FOLLICULAR LYMPHOMA (FL)
Volume: 100 Page(s): 270 - 270
06/01/2015 Authors: Sargent D; Shi QS; De Bedout S; Flowers C; Fowler N; Fu T; Hagenbeek A; Herold M; Hoster E; Huang J -
PROGNOSTIC TESTING PATTERNS IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN US PRACTICES FROM THE CONNECT (R) CLL REGISTRY
Volume: 100 Page(s): 679 - 680
06/01/2015 Authors: Mato A; Flowers CR; Farber CM; Weiss MA; Kipps TJ; Kozloff MF; Nabhan C; Flinn IW; Grinblatt DL; Lamanna N -
UBLITUXIMAB + TGR-1202 DEMONSTRATES ACTIVITY AND FAVORABLE SAFETY PROFILE IN RELAPSED/REFRACTORY B-CELL NHL AND HIGH-RISK CLL
Volume: 100 Page(s): 110 - 111
06/01/2015 Authors: Lunning MA; Vose JM; Fowler NH; Nastoupil L; Burger JA; Wierda WG; Schreeder MT; Siddiqi T; Flowers CR; Cohen JB -
IDELALISIB EFFICACY AND SAFETY IN FOLLICULAR LYMPHOMA PATIENTS FROM A PHASE 2 STUDY
Volume: 100 Page(s): 272 - 272
06/01/2015 Authors: Zinzani P; Salles G; Schuster SJ; de Vos S; Wagner-Johnston ND; Viardot A; Flowers CR; Will M; Breuleux M; Godfrey WR -
Impact of racial residential segregation (RRS) on stage at diagnosis and survival after diffuse large B-cell lymphoma (DLBCL).
Volume: 33
05/20/2015 Authors: Nastoupil LJ; Flowers C; Lichtensztajn D; Gomez SL; Williams J; Clarke CA; Keegan THM -
Safety and activity of the chemotherapy-free triplet of ublituximab, TGR-1202, and ibrutinib in relapsed B-cell malignancies.
Volume: 33
05/20/2015 Authors: Fowler NH; Nastoupil LJ; Lunning MA; Vose J; Siddiqi T; Flowers C; Cohen JB; Schreeder MT; Miguel M; Blumel S -
Prognostic testing patterns in CLL pts treated in US practices from the Connect CLL registry
Volume: 33
05/20/2015 Authors: Mato A; Flowers C; Farber CM; Weiss MA; Kipps TJ; Kozloff M; Nabhan C; Flinn I; Grinblatt DL; Lamanna N -
Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer
Volume: 33
05/20/2015 Authors: Goldstein DA; Ahmad BB; Chen Q; Ayer T; Howard DH; Lipscomb J; El-Rayes BF; Flowers C -
Ublituximab plus TGR-1202 activity and safety profile in relapsed/refractory B-cell NHL and high-risk CLL
Volume: 33
05/20/2015 Authors: Lunning MA; Vose J; Fowler NH; Nastoupil LJ; Schreeder MT; Siddiqi T; Flowers C; Cohen JB; Blumel S; Miguel M -
Idelalisib monotherapy and durable responses in patients with relapsed or refractory Waldenstroms Macroglobulinemia (WM)
Volume: 33
05/20/2015 Authors: Coutre S; Leonard J; Flowers C; Davies AJ; Jurczak W; Byrd JC; Spurgeon SEF; Peterman S; Holes L; Cho Y -
Idelalisib efficacy and safety in follicular lymphoma patients from a phase 2 study
Volume: 33
05/20/2015 Authors: Salles GA; Schuster SJ; De Vos S; Wagner-Johnston ND; Viardot A; Flowers C; Will M; Breuleux M; Godfrey WR; Sorensen B -
A phase I study of gemcitabine and bendamustine in relapsed/refractory Hodgkin's lymphoma
Volume: 33
05/20/2015 Authors: Cohen JB; Wei L; Maddocks KJ; Heffner LT; Langston AA; Flowers C; Devine SM; Blum KA -
Interim results from a dose-escalation study of the BCL-2 inhibitor venetoclax (ABT-199/GDC-0199) plus bendamustine (B) and rituximab (R) in patients (pts) with relapsed/refractory (R/R) Non-Hodgkin's Lymphoma (NHL)
Volume: 33
05/20/2015 Authors: De Vos S; Flowers C; Wang D; Swinnen LJ; Fowler NH; Reid EG; Cordero J; Gifford M; D'Amico D; Dunbar M -
New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.
Expert Rev Anticancer Ther Volume: 15 Page(s): 531 - 544
05/01/2015 Authors: Chihara D; Nastoupil LJ; Williams JN; Lee P; Koff JL; Flowers CR -
Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States.
Leuk Lymphoma Volume: 56 Page(s): 1295 - 1302
05/01/2015 Authors: Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Taylor M; Friedberg JW; Koff JL; Link BK; Cerhan JR; Dawson KL -
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Int J Radiat Oncol Biol Phys Volume: 92 Page(s): 107 - 112
05/01/2015 Authors: Jegadeesh N; Rajpara R; Esiashvili N; Shi Z; Liu Y; Okwan-Duodu D; Flowers CR; Khan MK -
Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique.
Int J Radiat Oncol Biol Phys Volume: 92 Page(s): 183 - 191
05/01/2015 Authors: Heumann TR; Esiashvili N; Parker S; Switchenko JM; Dhabbaan A; Goodman M; Lechowicz MJ; Flowers CR; Khan MK -
Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 15 Page(s): 270 - 277
05/01/2015 Authors: Davis CC; Cohen JB; Shah KS; Hutcherson DA; Surati MJ; Valla K; Panjic EH; Handler CE; Switchenko JM; Flowers CR -
Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non-hodgkin lymphoma (iNHL)
Volume: 169 Page(s): 54 - 54
04/01/2015 Authors: Davies A; Salles G; Wagner-Johnston N; Kahl B; De Vos S; Schuster S; Jurczak W; Flinn I; Flowers C; Martin P -
First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis.
J Clin Oncol Volume: 33 Page(s): 1112 - 1118
04/01/2015 Authors: Goldstein DA; Chen Q; Ayer T; Howard DH; Lipscomb J; El-Rayes BF; Flowers CR -
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Am J Epidemiol Volume: 181 Page(s): 406 - 421
03/15/2015 Authors: Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcn GS; Martinez-Maza O -
Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era.
Leuk Lymphoma Volume: 56 Page(s): 557 - 558
03/01/2015 Authors: Flowers CR; Cohen JB; Khan MK -
Costs and effectiveness of genomic testing in the management of colorectal cancer.
Oncology (Williston Park) Volume: 29 Page(s): 175 - 183
03/01/2015 Authors: Goldstein DA; Shaib WL; Flowers CR -
Comparing the cost-effectiveness of rituximab maintenance and radioimmunotherapy consolidation versus observation following first-line therapy in patients with follicular lymphoma.
Value Health Volume: 18 Page(s): 189 - 197
03/01/2015 Authors: Chen Q; Ayer T; Nastoupil LJ; Rose AC; Flowers CR -
Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.
J Clin Oncol Volume: 33 Page(s): 654 - 656
02/20/2015 Authors: Lyman GH; Bohlke K; Khorana AA; Kuderer NM; Lee AY; Arcelus JI; Balaban EP; Clarke JM; Flowers CR; Francis CW -
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
Leuk Lymphoma Volume: 56 Page(s): 383 - 389
02/01/2015 Authors: Nastoupil LJ; Shenoy PJ; Ambinder A; Koff JL; Nooka AK; Waller EK; Langston A; Seward M; Kaufman JL; Bernal-Mizrachi L -
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer (mPC).
Volume: 33
01/20/2015 Authors: Goldstein DA; Krishna K; Flowers C; El-Rayes BF; Bekaii-Saab TS; Noonan AM -
Next-generation prognostic assessment for diffuse large B-cell lymphoma.
Future Oncol Volume: 11 Page(s): 2443 - 2457
01/01/2015 Authors: Staton AD; Koff JL; Chen Q; Ayer T; Flowers CR -
Additional Support for Consolidative Radiotherapy for Diffuse Large B Cell Lymphoma in the Modern Rituximab Era.
Acta Haematol Volume: 134 Page(s): 109 - 110
01/01/2015 Authors: Khan MK; Esiashvili N; Flowers C -
Next-generation surveillance strategies for patients with lymphoma.
Future Oncol Volume: 11 Page(s): 1977 - 1991
01/01/2015 Authors: Cohen JB; Kurtz DM; Staton AD; Flowers CR -
Demographics By Age Group (AG) and Line of Therapy (LOT) in Chronic Lymphocytic Leukemia (CLL) Patients (Pts) Treated in US Practices from the Connect CLL Registry
Volume: 124
12/06/2014 Authors: Sharman JP; Mato A; Kay NE; Kipps TJ; Lamanna N; Weiss M; Nabhan C; Flinn I; Grinblatt DL; Kozloff MF -
Mature Follow up from a Phase 2 Study of PI3K-Delta Inhibitor Idelalisib in Patients with Double (Rituximab and Alkylating agent)-Refractory Indolent B-Cell Non-Hodgkin Lymphoma (iNHL)
Volume: 124
12/06/2014 Authors: Gopal AK; Kahl BS; de Vos S; Wagner-Johnston ND; Schuster SJ; Jurczak W; Flinn IW; Flowers CR; Martin P; Viardot A -
Determinants and Outcomes of the Use of Positron Emission Tomography (PET)-Staging in Newly Diagnosed Follicular Lymphoma (FL)
Volume: 124
12/06/2014 Authors: Rai A; Nastoupil LJ; Williams JN; Lipscomb J; Ward K; Howard DH; Flowers CR -
Rituximab Administration before Allogeneic HSCT Is Associated with Accelerated T Cell Reconstitution after Transplantation: Kinetic Evidence for a Graft-Versus-Leukemia Effect
Volume: 124
12/06/2014 Authors: Hosoba S; Flowers CR; Wu CJ; Wrammert JR; Waller EK -
The BCL-2 Inhibitor ABT-199 (GDC-0199) in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma
Volume: 124
12/06/2014 Authors: de Vos S; Flowers CR; Wang D; Swinnen LJ; Fowler N; Reid E; Gifford M; D'Amico D; Dunbar M; Zhu M -
Patterns of Care of Aged Chronic Lymphocytic Leukemia Patients in the United States: Systematic Analysis of 457 Patients in the Connect CLL Registry
Volume: 124
12/06/2014 Authors: Nabhan C; Galanina N; Kay NE; Mato AR; Grinblatt DL; Kipps TJ; Lamanna N; Weiss M; Flinn I; Swern AS -
Strand-Specific Total RNA Sequencing Establishes the Complete Transcriptome and Alternative Splicing Repertoire in Diffuse Large B Cell Lymphoma
Volume: 124
12/06/2014 Authors: Greenough A; Moffitt A; Jima D; Healy J; Patel A; Richards KL; Fedoriw YD; Dunphy C; Choi WWL; Srivastava G -
Insurance Status Impacts Survival in Follicular Lymphoma
BLOOD Volume: 124
12/06/2014 Authors: Nastoupil LJ; Han X; Jemal A; Ward E; Flowers CR -
Optimal disease surveillance strategies in non-Hodgkin lymphoma.
Hematology Am Soc Hematol Educ Program Volume: 2014 Page(s): 481 - 487
12/05/2014 Authors: Cohen JB; Flowers CR -
Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer.
Clin Colorectal Cancer Volume: 13 Page(s): 219 - 225
12/01/2014 Authors: Goldstein DA; Chen Q; Ayer T; Howard DH; Lipscomb J; Harvey RD; El-Rayes BF; Flowers CR -
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema.
Clin Lymphoma Myeloma Leuk Volume: 14 Page(s): e213 - e215
12/01/2014 Authors: Shams SR; Goldstein DA; Kaufman JL; MacKelfresh J; Flowers CR; Langston AA -
Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms.
Clin Lymphoma Myeloma Leuk Volume: 14 Page(s): 460 - 467.e2
12/01/2014 Authors: Read JA; Koff JL; Nastoupil LJ; Williams JN; Cohen JB; Flowers CR -
ACR appropriateness criteria follow-up of Hodgkin lymphoma.
J Am Coll Radiol Volume: 11 Page(s): 1026 - 1033.e3
11/01/2014 Authors: Ha CS; Hodgson DC; Advani R; Dabaja BS; Dhakal S; Flowers CR; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP -
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
Nat Genet Volume: 46 Page(s): 1233 - 1238
11/01/2014 Authors: Cerhan JR; Berndt SI; Vijai J; Ghesquires H; McKay J; Wang SS; Wang Z; Yeager M; Conde L; de Bakker PIW -
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
Ann Oncol Volume: 25 Page(s): 2211 - 2217
11/01/2014 Authors: Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R -
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Blood Volume: 124 Page(s): 2354 - 2361
10/09/2014 Authors: Petrich AM; Gandhi M; Jovanovic B; Castillo JJ; Rajguru S; Yang DT; Shah KA; Whyman JD; Lansigan F; Hernandez-Ilizaliturri FJ -
Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell Non-Hodgkin Lymphoma (iNHL)
ONCOLOGY RESEARCH AND TREATMENT Volume: 37 Page(s): 185 - 185
10/01/2014 Authors: Dreyling MH; Viardot A; Salles G; Wagner-Johnston ND; Kahl BS; De Vos S; Schuster SJ; Jurczak W; Flinn IW; Flowers C -
Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma
CANCER RESEARCH Volume: 74
10/01/2014 Authors: Cerhan JR; Berndt SI; Vijai J; Ghesquieres H; McKay J; Wang SS; Wang Z; Yeager M; Nieters A; Cox D -
Puffing the 'Activate' in Activated B Cell-like Diffuse Large B Cell Lymphoma: A Role for the Noncanonical NF-kappa B Pathway
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Volume: 14 Page(s): S143 - S143
09/01/2014 Authors: Koff JL; Guo X; Ramachandiran S; Switchenko JM; Mosunjac MB; Neill SG; Mann K; Bagirov M; Flowers CR; Lossos IS -
Predictors of Local Recurrence in Patients With Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab-Based Chemotherapy Alone: Guiding Decisions for Consolidative Radiation Therapy
Volume: 90 Page(s): S67 - S67
09/01/2014 Authors: Jegadeesh N; Esiashvili N; Shi Z; Flowers C; Liu Y; Khan M -
The Role of Consolidative Radiation Therapy in Early-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP-Based Immunochemotherapy
Volume: 90 Page(s): S66 - S66
09/01/2014 Authors: Rajpara RS; Shi Z; Esiashvili N; Flowers CR; Khan MK -
Total Skin Electron Irradiation (TSEI) Using Rotational Technique for Cutaneous T-Cell Lymphoma
Volume: 90 Page(s): S680 - S681
09/01/2014 Authors: Heumann TR; Esiashvili N; Parker S; Switchenko JM; Lechowicz M; Flowers C; Khan MK -
Routine use of maintenance therapy in follicular lymphoma: examine the rationale for maintenance use before uniformly adopting a strategy.
Oncology (Williston Park) Volume: 28 Page(s): 787 - 793
09/01/2014 Authors: Flowers CR -
Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
J Natl Cancer Inst Monogr Volume: 2014 Page(s): 15 - 25
08/01/2014 Authors: Cerhan JR; Kricker A; Paltiel O; Flowers CR; Wang SS; Monnereau A; Blair A; Dal Maso L; Kane EV; Nieters A -
Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
J Natl Cancer Inst Monogr Volume: 2014 Page(s): 26 - 40
08/01/2014 Authors: Linet MS; Vajdic CM; Morton LM; de Roos AJ; Skibola CF; Boffetta P; Cerhan JR; Flowers CR; de Sanjos S; Monnereau A -
Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
J Natl Cancer Inst Monogr Volume: 2014 Page(s): 66 - 75
08/01/2014 Authors: Wang SS; Flowers CR; Kadin ME; Chang ET; Hughes AM; Ansell SM; Feldman AL; Lightfoot T; Boffetta P; Melbye M -
Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
J Natl Cancer Inst Monogr Volume: 2014 Page(s): 76 - 86
08/01/2014 Authors: Smedby KE; Sampson JN; Turner JJ; Slager SL; Maynadi M; Roman E; Habermann TM; Flowers CR; Berndt SI; Bracci PM -
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
J Natl Cancer Inst Monogr Volume: 2014 Page(s): 130 - 144
08/01/2014 Authors: Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjos S; Smedby KE; Chiu BCH -
Incidence and geographic distribution of adult acute leukemia in the state of Georgia.
South Med J Volume: 107 Page(s): 497 - 500
08/01/2014 Authors: El Rassi F; Ward KC; Flowers CR; Heffner LT; Waller EK; Winton EF; Vaughn J; Hill BG; Langston A; Nooka A -
ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma.
Pediatr Blood Cancer Volume: 61 Page(s): 1305 - 1312
07/01/2014 Authors: Terezakis SA; Metzger ML; Hodgson DC; Schwartz CL; Advani R; Flowers CR; Hoppe BS; Ng A; Roberts KB; Shapiro R -
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.
Cancer Volume: 120 Page(s): 1830 - 1837
06/15/2014 Authors: Nastoupil LJ; Sinha R; Byrtek M; Zhou X; Taylor MD; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR -
Socioeconomic disparities in lymphoma.
Blood Volume: 123 Page(s): 3530 - 3531
06/05/2014 Authors: Flowers CR; Nastoupil LJ -
PATIENT-REPORTED OUTCOMES DATA FROM A PHASE 2 STUDY OF IDELALISIB IN PATIENTS WITH REFRACTORY INDOLENT B-CELL NON-HODGKIN LYMPHOMA (INHL)
Volume: 99 Page(s): 143 - 143
06/01/2014 Authors: Salles G; Wagner-Johnston ND; Kahl BS; De Vos S; Schuster SJ; Jurczak W; Flinn IW; Flowers C; Martin P; Viardot A -
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant Volume: 20 Page(s): 852 - 857
06/01/2014 Authors: Nooka AK; Johnson HR; Kaufman JL; Flowers CR; Langston A; Steuer C; Graiser M; Ali Z; Shah NN; Rangaraju S -
Differences in disease characteristics, treatment patterns, and outcomes between men (M) and women (W) with follicular lymphoma (FL): Prospective evaluation of 2,650 US patients (pts).
Volume: 32
05/20/2014 Authors: Nabhan C; Byrtek M; Dawson KL; Zhou X; Ziemiecki R; Zelenetz AD; Friedberg JW; Cerhan JR; Flowers C -
Cost-effectiveness analysis of pharmacokinetic-guided (PK) 5-fluorouracil (5FU) when combined with leucovorin and oxaliplatin (FOLFOX) chemotherapy for metastatic colorectal cancer (mCRC)
Volume: 32
05/20/2014 Authors: Goldstein DA; Chen Q; Howard DH; Lipscomb J; Ayer T; Harvey D; El-Rayes BF; Flowers C -
Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non Hodgkin lymphoma (iNHL)
Volume: 32
05/20/2014 Authors: Wagner-Johnston ND; Gopal AK; Kahl BS; De Vos S; Schuster SJ; Jurczak W; Flinn I; Flowers C; Martin P; Viardot A -
Peripheral T-cell lymphomas (PTCL) in the modern era: Prognosis and impact of therapy to a large US multicenter cohort.
Volume: 32
05/20/2014 Authors: Abramson JS; Feldman T; Kroll A; Muffly LS; Winer ES; Flowers C; Lansigan F; Nabhan C; Nath R; Castillo JJ -
Characteristics, treatments, and survival outcome of mantle cell lymphoma in women: A single center analysis.
Volume: 32
05/20/2014 Authors: Shams SR; Nastoupil LJ; Flowers C -
Mature response data from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)-refractory indolent B-cell non-Hodgkin lymphoma (iNHL)
Volume: 165 Page(s): 2 - 2
05/01/2014 Authors: Davies A; Gopal AK; Kahl BS; de Vos S; Wagner-Johnston ND; Schuster SJ; Jurczak WJ; Flinn IW; Flowers CR; Dansey R -
Insurance status is related to diffuse large B-cell lymphoma survival.
Cancer Volume: 120 Page(s): 1220 - 1227
04/15/2014 Authors: Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E -
PI3K inhibition by idelalisib in patients with relapsed indolent lymphoma.
N Engl J Med Volume: 370 Page(s): 1008 - 1018
03/13/2014 Authors: Gopal AK; Kahl BS; de Vos S; Wagner-Johnston ND; Schuster SJ; Jurczak WJ; Flinn IW; Flowers CR; Martin P; Viardot A -
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.
Bone Marrow Transplant Volume: 49 Page(s): 185 - 189
02/01/2014 Authors: Langston AA; Prichard JM; Muppidi S; Nooka A; Lechowicz MJ; Lonial S; Sinha R; Graiser M; Kaufman JL; Khoury HJ -
Simplified Technique for Administration of High Dose Melphalan
Volume: 20 Page(s): S291 - S292
02/01/2014 Authors: Hutcherson D; Valla K; Shah KS; Surati M; French K; Nooka A; Kaufman J; Lonial S; Cohen JB; Langston A -
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
Cancer Volume: 119 Page(s): 4129 - 4136
12/01/2013 Authors: Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK -
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 13 Page(s): 657 - 663
12/01/2013 Authors: Sinha R; Shenoy PJ; King N; Lechowicz MJ; Bumpers K; Hutcherson D; Arellano M; Langston A; Kaufman J; Heffner LT -
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.
Cancer Volume: 119 Page(s): 4119 - 4128
12/01/2013 Authors: Nooka AK; Kaufman JL; Behera M; Langston A; Waller EK; Flowers CR; Gleason C; Boise LH; Lonial S -
Relationship Between Residential Proximity To Environmental Protection Agency (EPA) Designated Toxic Release Sites and The Risk Of Diffuse Large B-Cell Lymphoma (DLBCL)
Volume: 122
11/15/2013 Authors: Bulka C; Nastoupil LJ; Koff J; Bernal L; Ward K; Bayakly R; Switchenko J; Waller L; Flowers CR -
Comparing The Cost-Effectiveness Of Rituximab Maintenance (MR) and Radioimmunotherapy (RIT) Consolidation Therapy Following First-Line Chemo/Immunochemotherapies For Follicular Lymphoma
Volume: 122
11/15/2013 Authors: Chen Q; Ayer T; Rose AC; Nastoupil LJ; Flowers CR -
Spatial Epidemiology Of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma In The State Of Georgia
Volume: 122
11/15/2013 Authors: Bulka C; Nastoupil LJ; Switchenko J; Ward K; Bayakly R; Waller L; Flowers CR -
Disease Characteristics, Patterns Of Care, and Outcomes Of Follicular Lymphoma (FL) In The Oldest Old
Volume: 122
11/15/2013 Authors: Nastoupil LJ; Rai A; Lipscomb J; Nabhan C; Williams JN; Ward K; Howard DH; Flowers CR -
Patterns Of First-Line Management Strategies In Older Adults With Follicular Lymphoma (FL)
Volume: 122
11/15/2013 Authors: Rai A; Nastoupil LJ; Williams JN; Lipscomb J; Ward K; Howard DH; Flowers CR -
Mature Response Data From a Phase 2 Study Of PI3K-Delta Inhibitor Idelalisib In Patients With Double (Rituximab and Alkylating Agent)-Refractory Indolent B-Cell Non-Hodgkin Lymphoma (iNHL)
Volume: 122
11/15/2013 Authors: Gopal A; Kahl BS; De Vos S; Wagner-Johnston ND; Schuster SJ; Blum KA; Jurczak WJ; Flinn IW; Flowers CR; Martin P -
Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America
Volume: 122
11/15/2013 Authors: Flowers CR; Lill M; Costa LJ; Shore TB; Vaughan W; Craig M; Freytes CO; Shea TC; Horwitz ME; Fay JW -
Early Relapse Of Follicular Lymphoma After R-CHOP Uniquely Defines Patients At High Risk For Death: An Analysis From The National Lymphocare Study
Volume: 122
11/15/2013 Authors: Casulo C; Byrtek M; Dawson KL; Zhou X; Farber C; Flowers CR; Hainsworth JD; Link BK; Zelenetz AD; Friedberg JW -
A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients
BLOOD Volume: 122
11/15/2013 Authors: Nabhan C; Byrtek M; Dawson KL; Zhou X; Link BK; Friedberg JW; Zelenetz AD; Cerhan JR; Flowers CR -
Patterns and Outcomes Of First-Line Management Strategies In Older Adults With Low-Grade Follicular Lymphoma (FL)
Volume: 122
11/15/2013 Authors: Rai A; Nastoupil LJ; Lipscomb J; Ward K; Howard DH; Flowers CR -
Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma
Volume: 122
11/15/2013 Authors: Scotland P; Gaulard P; Love CL; Fataccioli V; Travert M; De Leval L; Weisenburger DD; Czader M; Parihar M; Nair R -
PET Compared With CT As a Prognosticator After Rituximab Induction Therapy In Follicular Lymphoma: Report From The National Lymphocare Study
Volume: 122 Page(s): 4245 - 4249
11/15/2013 Authors: Wong-Sefidan I; Byrtek M; Zhou X; Friedberg JW; Flowers C; Link BK; Zelenetz AD; Dawson KL; Reid EG -
Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.
J Clin Oncol Volume: 31 Page(s): 4132 - 4139
11/10/2013 Authors: Evens AM; Advani R; Press OW; Lossos IS; Vose JM; Hernandez-Ilizaliturri FJ; Robinson BK; Otis S; Nadav Dagan L; Abdallah R -
Racial differences in chronic lymphocytic leukemia. Digging deeper.
Cancer Volume: 119 Page(s): 3593 - 3595
10/15/2013 Authors: Flowers CR; Pro B -
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.
Support Care Cancer Volume: 21 Page(s): 2853 - 2860
10/01/2013 Authors: Pashos CL; Flowers CR; Kay NE; Weiss M; Lamanna N; Farber C; Lerner S; Sharman J; Grinblatt D; Flinn IW -
Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
Oncology (Williston Park) Volume: 27 Suppl 2 Page(s): 8 - 12
10/01/2013 Authors: Nastoupil LJ; Koff JL; Flowers CR -
Renewed interest in the role of consolidative radiotherapy in advanced stage diffuse large B-cell lymphoma.
Leuk Lymphoma Volume: 54 Page(s): 2122 - 2130
10/01/2013 Authors: Shi Z; Esiashvili N; Flowers C; Das S; Khan MK -
Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma.
Cancer Volume: 119 Page(s): 3309 - 3317
09/15/2013 Authors: Bulka C; Nastoupil LJ; McClellan W; Ambinder A; Phillips A; Ward K; Bayakly AR; Switchenko JM; Waller L; Flowers CR -
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
Biol Blood Marrow Transplant Volume: 19 Page(s): 1393 - 1395
09/01/2013 Authors: Harvey RD; Kaufman JL; Johnson HR; Nooka A; Vaughn L; Flowers CR; Khoury HJ; Lechowicz MJ; Langston AA; Lonial S -
The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy.
Expert Rev Anticancer Ther Volume: 13 Page(s): 1089 - 1108
09/01/2013 Authors: Nastoupil LJ; Sinha R; Flowers CR -
Peripheral T-cell lymphoma: what's the role for transplant?
Oncology (Williston Park) Volume: 27 Page(s): 891 - 892
09/01/2013 Authors: Cohen JB; Flowers CR -
ACR Appropriateness Criteria: Localized nodal indolent lymphoma.
Oncology (Williston Park) Volume: 27 Page(s): 786 - 794
08/01/2013 Authors: Hoppe BS; Hodgson DC; Advani R; Dabaja BS; Flowers CR; Ha CS; Metzger ML; Plastaras JP; Roberts KB; Shapiro R -
Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy.
Int J Radiat Oncol Biol Phys Volume: 86 Page(s): 569 - 577
07/01/2013 Authors: Shi Z; Das S; Okwan-Duodu D; Esiashvili N; Flowers C; Chen Z; Wang X; Jiang K; Nastoupil LJ; Khan MK -
Communicating safe outpatient management of fever and neutropenia.
J Oncol Pract Volume: 9 Page(s): 207 - 210
07/01/2013 Authors: Flowers CR; Karten C -
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
J Clin Oncol Volume: 31 Page(s): 2189 - 2204
06/10/2013 Authors: Lyman GH; Khorana AA; Kuderer NM; Lee AY; Arcelus JI; Balaban EP; Clarke JM; Flowers CR; Francis CW; Gates LE -
Variation in health-related quality of life (HRQOL) by line of therapy, age, and gender among patients with chronic lymphocytic leukemia.
Volume: 31
05/20/2013 Authors: Flowers C; Farber CM; Flinn I; Grinblatt DL; Kay NE; Kipps TJ; Kozloff M; Lamanna N; Lerner S; Sharman JP -
Survival outcomes of plasma cell leukemia (PCL) in the United States: A SEER analysis
Volume: 31
05/20/2013 Authors: Ravipati HP; Kaufman JL; Langston AA; Boise L; Flowers C; Lonial S; Nooka AK -
Outcomes of hematopoietic stem cell transplant recipients admitted to the medical intensive care unit.
Volume: 31
05/20/2013 Authors: Duc QT; Langston AA; Waller EK; Simon M; Gleason C; Casbourne D; Fisher M; Kaufman JL; Flowers C; Lonial S -
Certification and role of local pathologists for diffuse large B-cell lymphoma (DLBCL) subtyping and eligibility determination in the phase II PYRAMID study
Volume: 31
05/20/2013 Authors: Said JW; Reeves JA; Flinn I; Tulpule A; Robles RL; Flowers C; DiBella NJ; Kolibaba KS; Venugopal P; Kolevska T -
Patterns of failure in advanced-stage diffuse large B-cell lymphoma (DLBCL) patients treated with R-CHOP chemotherapy and the emerging role of consolidative radiotherapy
Volume: 31
05/20/2013 Authors: Shi ZJ; Das S; Okwan-Duodu D; Esiashvili N; Flowers C; Jiang K; Chen Z; Wang X; Curran WJ; Khan MK -
Using primary site as a predictor of survival in mantle cell lymphoma.
Cancer Volume: 119 Page(s): 1570 - 1577
04/15/2013 Authors: Ambinder AJ; Shenoy PJ; Nastoupil LJ; Flowers CR -
Single centre pharmacoeconomic analysis of palifermin in autologous stem cell transplantation
Volume: 48 Page(s): S453 - S453
04/01/2013 Authors: Johnson HR; Nooka A; Kaufman J; Flowers C; Langston A; Graiser M; Plummer T; Lonial S; Waller E -
Incidence and survival patterns of cutaneous T-cell lymphomas in the United States.
Leuk Lymphoma Volume: 54 Page(s): 752 - 759
04/01/2013 Authors: Imam MH; Shenoy PJ; Flowers CR; Phillips A; Lechowicz MJ -
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Biol Blood Marrow Transplant Volume: 19 Page(s): 460 - 467
03/01/2013 Authors: Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK -
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
J Clin Oncol Volume: 31 Page(s): 794 - 810
02/20/2013 Authors: Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KVI -
Results of a Phase 2 Clinical Trial Testing the Efficacy of Plerixafor in Combination with Chemotherapy in the Mobilization of Autologous Blood Hematopoietic Progenitor Cells
Volume: 19 Page(s): S191 - S191
02/01/2013 Authors: Waller EK; Johnson HR; Jagirdar N; Gaylor C; Lipscomb C; Flowers C; Kaufman J; Khoury HJ; Langston A; Lechowicz M -
Examining racial differences in diffuse large B-cell lymphoma presentation and survival.
Leuk Lymphoma Volume: 54 Page(s): 268 - 276
02/01/2013 Authors: Flowers CR; Shenoy PJ; Borate U; Bumpers K; Douglas-Holland T; King N; Brawley OW; Lipscomb J; Lechowicz MJ; Sinha R -
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.
Ann Oncol Volume: 24 Page(s): 441 - 448
02/01/2013 Authors: Nooka AK; Nabhan C; Zhou X; Taylor MD; Byrtek M; Miller TP; Friedberg JW; Zelenetz AD; Link BK; Cerhan JR -
Genetic heterogeneity of diffuse large B-cell lymphoma.
Proc Natl Acad Sci U S A Volume: 110 Page(s): 1398 - 1403
01/22/2013 Authors: Zhang J; Grubor V; Love CL; Banerjee A; Richards KL; Mieczkowski PA; Dunphy C; Choi W; Au WY; Srivastava G -
American Cancer Society lung cancer screening guidelines.
CA Cancer J Clin Volume: 63 Page(s): 107 - 117
01/01/2013 Authors: Wender R; Fontham ETH; Barrera E; Colditz GA; Church TR; Ettinger DS; Etzioni R; Flowers CR; Gazelle GS; Kelsey DK -
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma.
Transfusion Volume: 53 Page(s): 76 - 84
01/01/2013 Authors: Kaufman JL; Flowers CR; Rados KD; Calandra GB; Vose JM; Hewes LB; Lonial S; Langston AA; Khoury HJ; Lechowicz MJ -
Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin Lymphoma - a commentary on report from Krull and colleagues.
Transl Pediatr Volume: 2 Page(s): 1 - 2
01/01/2013 Authors: Esiashvili N; Khan M; Flowers C -
The genetic landscape of mutations in Burkitt lymphoma.
Nat Genet Volume: 44 Page(s): 1321 - 1325
12/01/2012 Authors: Love C; Sun Z; Jima D; Li G; Zhang J; Miles R; Richards KL; Dunphy CH; Choi WWL; Srivastava G -
A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 12 Page(s): 393 - 399
12/01/2012 Authors: Rose AC; Shenoy PJ; Garrett G; Seward M; Kucuk RA; Doksansky H; Nastoupil LJ; Flowers CR -
Management of relapsed chronic lymphocytic leukemia: applying guidelines to practice.
Community Oncol Volume: 9 Page(s): S85 - S92
12/01/2012 Authors: Nastoupil LJ; Flowers CR -
Age Differences in Disease Characteristics, Patterns of Care, and Outcomes of Follicular Lymphoma (FL) in the United States (US): Report From the National Lymphocare Study (NLCS)
Volume: 120
11/16/2012 Authors: Nabhan C; Byrtek M; Latta S; Dawson KL; Zhou X; Link BK; Friedberg JW; Cerhan JR; Flowers CR -
Patterns of Delivery of Chemoimmunotherapy to Patients with Follicular Lymphoma in the United States: Results of the National Lymphocare Study
Volume: 120
11/16/2012 Authors: Martin P; Link BK; Byrtek M; Dawson KL; Ziemiecki RM; Friedberg JW; Cerhan JR; Flowers CR -
GM-CSF and IL-4 Derived Fusion Cytokine Reprograms Leukemic B-Cells to Anti-CLL Effectors
Volume: 120
11/16/2012 Authors: Deng J; Pennati A; Li P; Yuan S; Murphy J; Ng S; Sinha R; Flowers CR; Galipeau J -
Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry
Volume: 120
11/16/2012 Authors: Hailemichael E; Kaufman JL; Flowers CR; Waller EK; Lechowicz MJ; Langston A; Graiser M; Boise LH; Lonial S; Nooka AK -
Do Elderly Myeloma Patients Benefit From High Dose Therapy (HDT) and Autologous Stem Cell Transplant (ASCT)?: A Comparative Survival Analysis using SEER Registry
Volume: 120
11/16/2012 Authors: Hailemichael E; Kaufman JL; Flowers CR; Waller EK; Lechowicz MJ; Langston A; Graiser M; Boise LH; Lonial S; Nooka AK -
Survival of Newly Diagnosed T-Cell Lymphoma (TCL) in the Modern Era: Investigation of Prognostic Factors with Critical Examination of Therapy in a Multicenter US Cohort
Volume: 120
11/16/2012 Authors: Evens AM; Feldman T; Kroll A; Muffly LS; Winer E; Flowers C; Lansigan F; Nabhan C; Nastoupil L; Kim A -
Considerations in the initial management of follicular lymphoma.
Community Oncol Volume: 9 Page(s): S53 - S60
11/01/2012 Authors: Nastoupil L; Sinha R; Hirschey A; Flowers CR -
Initial management strategies for follicular lymphoma.
Int J Hematol Oncol Volume: 1 Page(s): 35 - 45
10/01/2012 Authors: Chen Q; Ayer T; Nastoupil LJ; Seward M; Zhang H; Sinha R; Flowers CR -
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study.
Cancer Volume: 118 Page(s): 4842 - 4850
10/01/2012 Authors: Nabhan C; Byrtek M; Taylor MD; Friedberg JW; Cerhan JR; Hainsworth JD; Miller TP; Hirata J; Link BK; Flowers CR -
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.
J Clin Oncol Volume: 30 Page(s): 3368 - 3375
09/20/2012 Authors: Friedberg JW; Byrtek M; Link BK; Flowers C; Taylor M; Hainsworth J; Cerhan JR; Zelenetz AD; Hirata J; Miller TP -
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase.
Br J Haematol Volume: 158 Page(s): 608 - 614
09/01/2012 Authors: Muringampurath-John D; Jaye DL; Flowers CR; Saxe D; Chen Z; Lechowicz MJ; Weisenburger DD; Bast M; Arellano ML; Bernal-Mizrachi L -
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States.
Cancer Epidemiol Biomarkers Prev Volume: 21 Page(s): 1520 - 1530
09/01/2012 Authors: Flowers CR; Fedewa SA; Chen AY; Nastoupil LJ; Lipscomb J; Brawley OW; Ward EM -
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Biol Blood Marrow Transplant Volume: 18 Page(s): 1287 - 1294
08/01/2012 Authors: Zhang H; Graiser M; Hutcherson DA; Dada MO; McMillan S; Ali Z; Flowers CR; Waller EK -
EVALUATION OF THE USE AND EFFICACY OF RITUXIMAB (R) MAINTENANCE REGIMENS IN US PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA (FL): DATA FROM THE NATIONAL LYMPHOCARE STUDY 2004-2007
Volume: 97 Page(s): 95 - 96
07/16/2012 Authors: Nastoupil L; Sinha R; Byrtek M; Zhou X; Taylor M; Friedberg J; Link B; Cerhan J; Dawson K; Flowers C -
EFFECTIVENESS OF FIRST-LINE CHEMOIMMUNOTHERAPY REGIMENS FOR PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA (FL) IN THE US: DATA FROM THE NATIONAL LYMPHOCARE STUDY (NLCS)
Volume: 97 Page(s): 328 - 328
07/16/2012 Authors: Nastoupil L; Sinha R; Byrtek M; Ziemiecki R; Taylor M; Friedberg J; Link B; Cerhan J; Dawson K; Flowers C -
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Cancer Volume: 118 Page(s): 3538 - 3548
07/15/2012 Authors: Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT -
VARIATION IN HEALTH-RELATED QUALITY OF LIFE BY AGE AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
VALUE IN HEALTH Volume: 15 Page(s): A226 - A226
06/01/2012 Authors: Pashos CL; Flowers CR; Weiss M; Lamanna N; Farber C; Kipps TJ; Lerner S; Kay N; Sharman J; Grinblatt DL -
Variation in health-related quality of life (HRQOL) by ECOG performance status (PS) and fatigue among patients with chronic lymphocytic leukemia (CLL).
Volume: 30
05/20/2012 Authors: Flowers C; Pashos CL; Weiss MA; Lamanna N; Farber CM; Kipps TJ; Lerner S; Kay NE; Sharman JP; Grinblatt DL -
Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Eur Oncol Haematol Volume: 8 Page(s): 123 - 126
05/01/2012 Authors: Nastoupil LJ; Sinha R; Flowers CR -
Diffuse large B-cell lymphoma: current treatment approaches.
Oncology (Williston Park) Volume: 26 Page(s): 488 - 495
05/01/2012 Authors: Nastoupil LJ; Rose AC; Flowers CR -
Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future.
Blood Lymphat Cancer Volume: 2012 Page(s): 87 - 98
04/19/2012 Authors: Sinha R; Nastoupil L; Flowers CR -
Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma.
Leuk Lymphoma Volume: 53 Page(s): 725 - 727
04/01/2012 Authors: Muringampurath-John D; Flowers CR; Toscano M; Zhengjia C; Kaufman JL; Arellano M; Bernal-Mizrachi L; Heffner LT; Lechowicz M-J; McLemore M -
Racial Differences in Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
Volume: 25 Page(s): 328A - 328A
02/01/2012 Authors: Chastain EC; Fisher KE; Bumpers K; Reddy V; Fu K; Flowers CR; Jaye DL -
Racial Differences in Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
Volume: 92 Page(s): 328A - 328A
02/01/2012 Authors: Chastain EC; Fisher KE; Bumpers K; Reddy V; Fu K; Flowers CR; Jaye DL -
BI-MODAL AGE DISTRIBUTION OF PATIENTS WITH RELAPSED HODGKIN LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION CORRELATES WITH MARKEDLY INFERIOR SURVIVAL AMONG PATIENTS AGE 35 YEARS AND OLDER
Volume: 18 Page(s): S296 - S296
02/01/2012 Authors: Sharma A; Duan M; Chowdhury R; Graiser M; Zhang H; Langston A; Lonial S; Flowers CR; Haight A; Waller EK -
Exploring risk factors for follicular lymphoma.
Adv Hematol Volume: 2012 Page(s): 626035
01/01/2012 Authors: Ambinder AJ; Shenoy PJ; Malik N; Maggioncalda A; Nastoupil LJ; Flowers CR -
New Challenges in the Management of Diffuse Large B-Cell Lymphoma.
Treat Strategies Hematol Volume: 2 Page(s): 68 - 73
01/01/2012 Authors: Flowers CR; Nastoupil LJ; Bernal-Mizrachi L; Rose AC; Sinha R -
Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Clin Lymphoma Myeloma Leuk Volume: 11 Page(s): 498 - 506
12/01/2011 Authors: Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR -
Equivalent Survival Following Fludarabine/Melphalan Reduced Intensity Conditioning with or without Rabbit ATG As Part of GvHD Prophylaxis
Volume: 118 Page(s): 855 - 856
11/18/2011 Authors: Prichard JM; Muppidi S; Flowers CR; Kaufman JL; Lechowicz MJ; Lonial S; Nooka AK; Sinha R; Waller EK; Langston A -
The Improved Efficacy of Bortezomib Containing Induction Regimens (BCIR) Versus Non-Bortezomib Containing Induction Regimens (NBCIR) in Transplant-Eligible Patients with Multiple Myeloma (MM): Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)
Volume: 118 Page(s): 1709 - 1710
11/18/2011 Authors: Nooka AK; Kaufman JL; Behera M; Gleason C; Langston A; Steuer CE; Flowers CR; Boise LH; Lonial S -
Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)
Volume: 118 Page(s): 707 - 708
11/18/2011 Authors: Sinha R; King N; Shenoy PJ; Lechowicz MJ; Bumpers K; Hutcherson D; Arellano M; Langston A; Kaufman JL; Heffner LT -
Temporal Changes in Plerixafor Administration Do Not Impact Hematopoietic Stem Cell Mobilization Efficacy: Results of a Prospective Clinical Trial
Volume: 118 Page(s): 1287 - 1288
11/18/2011 Authors: Harvey RD; Lonial S; Renfroe H; Sinha R; Flowers CR; Lechowicz MJ; Khoury HJ; Langston A; Waller EK; Kaufman JL -
A Predictive Model of Overall Survival (OS) for Patients with Relapsed/Refractory Multiple Myeloma (MM) Enrolling in Phase I Clinical Trials
BLOOD Volume: 118 Page(s): 1691 - 1691
11/18/2011 Authors: Nooka AK; Muppidi S; Harvey RD; Kaufman JL; Langston A; Lewis C; Boise LH; Flowers CR; Lonial S -
A Systematic Review and Meta-Analysis of Radioimmunotherapy Consolidation for Untreated Patients with Follicular Lymphoma (FL)
Volume: 118 Page(s): 49 - 49
11/18/2011 Authors: Rose AC; Garrett G; Seward M; Shenoy PT; Kucuk RA; Doksansky H; Flowers CR -
Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia
Volume: 118 Page(s): 914 - 915
11/18/2011 Authors: Pashos CL; Flowers CR; Weiss M; Lamanna N; Farber CM; Kipps TJ; Lerner S; Kay N; Sharman JP; Grinblatt DL -
A Comparison of the Effectiveness of First-Line Chemoimmunotherapy Regimens for Follicular Lymphoma (FL) Used in the United States
Volume: 118 Page(s): 47 - 47
11/18/2011 Authors: Nastoupil L; Sinha R; Byrtek M; Taylor M; Cerhan JR; Friedberg J; Link BK; Ziemiecki RM; Hirata JH; Flowers CR -
Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect (R) CLL Disease Registry
Volume: 118 Page(s): 1235 - 1236
11/18/2011 Authors: Sharman J; Flowers CR; Weiss M; Grinblatt D; Farber C; Kay N; Kipps T; Lamanna N; Pashos C; Flinn IW -
Whole Genome and Exome Sequencing Reveals the Genetic Landscape of Burkitt Lymphoma
Volume: 118 Page(s): 199 - 200
11/18/2011 Authors: Love CL; Jima D; Zhang J; Grubor V; Miles RR; Dunphy CH; Richards KL; Choi WWL; Au WY; Srivastava G -
Characteristics and Effectiveness of Rituximab (R) Maintenance Regimens Among US Patients Diagnosed with Follicular Lymphoma (FL) 2004-2007
Volume: 118 Page(s): 1584 - 1585
11/18/2011 Authors: Nastoupil L; Sinha R; Byrtek M; Zhou X; Taylor M; Cerhan JR; Friedberg J; Link BK; Hirata JH; Flowers CR -
Examining the Outcomes of Watchful Waiting (WW) Among US Patients with Advanced Stage Follicular Lymphoma (FL)
Volume: 118 Page(s): 351 - 351
11/18/2011 Authors: Sinha R; Byrtek M; DeJoubner NJ; Nooka AK; Taylor M; Cerhan JR; Friedberg J; Ziemiecki RM; Hirata JH; Link BK -
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
Transfusion Volume: 51 Page(s): 2175 - 2182
10/01/2011 Authors: Li J; Hamilton E; Vaughn L; Graiser M; Renfroe H; Lechowicz MJ; Langston A; Prichard JM; Anderson D; Gleason C -
Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature.
Clin Lymphoma Myeloma Leuk Volume: 11 Page(s): 379 - 384
10/01/2011 Authors: Nooka A; Shenoy PJ; Sinha R; Lonial S; Flowers CR -
Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?
Int J Radiat Oncol Biol Phys Volume: 81 Page(s): 175 - 180
09/01/2011 Authors: Kahn S; Flowers C; Xu Z; Esiashvili N -
A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation.
Transfusion Volume: 51 Page(s): 1779 - 1783
08/01/2011 Authors: Renfroe H; Arnold M; Vaughn L; Harvey RD; Hamilton E; Lonial S; Khoury HJ; Kaufman JL; Lechowicz MJ; Flowers CR -
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.
J Clin Oncol Volume: 29 Page(s): 2787 - 2794
07/10/2011 Authors: Schuster SJ; Neelapu SS; Gause BL; Janik JE; Muggia FM; Gockerman JP; Winter JN; Flowers CR; Nikcevich DA; Sotomayor EM -
SHOULD RADIATION THERAPY (XRT) BE THE STANDARD THERAPEUTIC APPROACH FOR STAGE I FOLLICULAR LYMPHOMA (FL)? A COMPARATIVE EFFECTIVENESS ANALYSIS OF THE NATIONAL LYMPHOCARE STUDY (NLCS)
Volume: 22 Page(s): 90 - 90
06/01/2011 Authors: Friedberg J; Byrtek M; Link B; Flowers C; Taylor M; Hainsworth J; Cerhan J; Hirata J; Miller T -
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Cancer Volume: 117 Page(s): 2530 - 2540
06/01/2011 Authors: Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR -
Second-line therapy in follicular lymphoma in the United States: Report of NLCS observational study
JOURNAL OF CLINICAL ONCOLOGY Volume: 29
05/20/2011 Authors: Link BK; Miller TP; Byrtek M; Cerhan JR; Zelenetz AD; Dillon H; Flowers C; Friedberg JW -
Second-line therapy in follicular lymphoma in the United States: Report of NLCS observational study.
J Clin Oncol Volume: 29 Page(s): 8049
05/20/2011 Authors: Link BK; Miller TP; Byrtek M; Cerhan JR; Zelenetz AD; Dillon H; Flowers C; Friedberg JW -
Examination of the Follicular Lymphoma International Prognostic Index (FLIPI) in the National LymphoCare Study (NLCS): A U.S. patient cohort treated predominantly in community practices.
J Clin Oncol Volume: 29 Page(s): 8036
05/20/2011 Authors: Nooka AK; DeJoubner NJ; Nabhan C; Zhou X; Taylor M; Byrtek M; Miller TP; Friedberg JW; Zelenetz AD; Link BK -
Novel agents for diffuse large B-cell lymphoma.
Expert Opin Investig Drugs Volume: 20 Page(s): 669 - 680
05/01/2011 Authors: Sinha R; DeJoubner N; Flowers C -
ACR Appropriateness Criteria on Hodgkin's lymphoma-unfavorable clinical stage I and II.
J Am Coll Radiol Volume: 8 Page(s): 302 - 308
05/01/2011 Authors: Das P; Ng A; Constine LS; Advani R; Flowers C; Friedberg J; Hodgson DC; Schwartz CL; Wilder RB; Wilson LD -
CORRELATION OF PATIENT CHARACTERISTICS INCLUDING AGE, OBESITY, GENDER AND RACE ON THE METABOLISM OF BUSULFAN
Volume: 17 Page(s): S352 - S353
02/01/2011 Authors: Hutcherson DA; Mahoney M; Ng A; Wilson NM; Surati M; Shah KS; Flowers CR -
Clinical, molecular, and environmental risk factors for hodgkin lymphoma.
Adv Hematol Volume: 2011 Page(s): 736261
01/01/2011 Authors: Maggioncalda A; Malik N; Shenoy P; Smith M; Sinha R; Flowers CR -
Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.
Expert Opin Biol Ther Volume: 11 Page(s): 31 - 40
01/01/2011 Authors: Abouyabis AN; Shenoy PJ; Lechowicz MJ; Flowers CR -
Idiotype vaccine strategies for treatment of follicular lymphoma.
Future Oncol Volume: 7 Page(s): 111 - 122
01/01/2011 Authors: Mahaseth H; Brody JD; Sinha R; Shenoy PJ; Flowers CR -
Incidence patterns and outcomes for hodgkin lymphoma patients in the United States.
Adv Hematol Volume: 2011 Page(s): 725219
01/01/2011 Authors: Shenoy P; Maggioncalda A; Malik N; Flowers CR -
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.
ISRN Hematol Volume: 2011 Page(s): 623924
01/01/2011 Authors: Abouyabis AN; Shenoy PJ; Sinha R; Flowers CR; Lechowicz MJ -
Patterns of social support among lymphoma patients considering stem cell transplantation.
Soc Work Health Care Volume: 50 Page(s): 815 - 827
01/01/2011 Authors: Glover R; Shenoy PJ; Kharod GA; Schaefer A; Bumpers K; Berry JTM; Flowers CR -
Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis.
Oncology Volume: 81 Page(s): 12 - 20
01/01/2011 Authors: Saba NF; Goodman M; Ward K; Flowers C; Ramalingam S; Owonikoko T; Chen A; Grist W; Wadsworth T; Beitler JJ -
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes.
Blood Volume: 116 Page(s): 5285 - 5288
12/09/2010 Authors: David E; Kaufman JL; Flowers CR; Schafer-Hales K; Torre C; Chen J; Marcus AI; Sun S-Y; Boise LH; Lonial S -
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
Blood Volume: 116 Page(s): e118 - e127
12/02/2010 Authors: Jima DD; Zhang J; Jacobs C; Richards KL; Dunphy CH; Choi WWL; Au WY; Srivastava G; Czader MB; Rizzieri DA -
A decade of progress in lymphoma: advances and continuing challenges.
Clin Lymphoma Myeloma Leuk Volume: 10 Page(s): 414 - 423
12/01/2010 Authors: Flowers CR; Armitage JO -
Use of Rituximab with CHOP Chemotherapy Appears to Overcome Racial Disparities In Survival In Black Patients with Diffuse Large B Cell Lymphoma When Compared to CHOP Chemotherapy Alone.
Volume: 116 Page(s): 650 - 650
11/19/2010 Authors: Borate U; Shenoy PJ; Donnellan W; Bumpers K; Douglas-Holland T; King N; Lechowicz MJ; The A; Jaye DL; Reddy V -
Cost-Effectiveness Analysis of a "Just-In-Time" Strategy of Salvage Plerixafor Administration for Poor-Mobilizing Patients Undergoing Autologous Transplant.
Volume: 116 Page(s): 923 - 924
11/19/2010 Authors: Li J; Hamilton E; Vaughn L; Graiser M; Repfroe H; Kaufman JL; Lonial S; Flowers CR; Lechowicz MJ; Langston A -
Examining the Racial Disparities In Presentation and Treatment for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).
Volume: 116 Page(s): 647 - 647
11/19/2010 Authors: Shenoy PJ; Borate U; Bumpers K; Douglas-Holland T; King N; Lechowicz MJ; Jaye DL; Donnellan W; The A; Reddy V -
Disease Characteristics and Patterns of Care In Elderly Patients (80+ years) with Follicular Lymphoma (FL) In the United States (US); Are Older Patients Treated Differently? Report From the National LymphoCare Study (NLCS)
Volume: 116 Page(s): 1690 - 1690
11/19/2010 Authors: Nabhan C; Byrtek M; Taylor M; Tydell J; Hirata JH; Flowers CR -
Does An Anthracycline Make a Difference for Follicular Lymphoma (FL) Grade 3? Patterns of Care and Treatment Outcomes of Grade 3 FL From the National LymphoCare Study (NLCS)
Volume: 116 Page(s): 737 - 737
11/19/2010 Authors: Flowers CR; Taylor M; Byrtek M; Hirata JH; Cerhan J; Hainsworth J; Link B; Miller TP; Dillon H; Friedberg JW -
Alternative Splicing Is a Major Mechanism of Gene Regulation In Diffuse Large B Cell Lymphoma
Volume: 116 Page(s): 351 - 352
11/19/2010 Authors: Jacobs CL; Patel A; Jima D; Liu Q; Greenough A; Zhang J; Dunphy C; Richards K; Choi W; Srivastava G -
Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Volume: 116 Page(s): 584 - 584
11/19/2010 Authors: Zhang H; Graiser M; Hutcherson D; Dada MO; McMillan S; Zahir A; Flowers CR; Waller E -
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
Transfusion Volume: 50 Page(s): 2424 - 2431
11/01/2010 Authors: Akhtari M; Giver CR; Ali Z; Flowers CR; Gleason CL; Hillyer CD; Kaufman J; Khoury HJ; Langston AA; Lechowicz MJ -
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.
Clin Cancer Res Volume: 16 Page(s): 5079 - 5086
10/15/2010 Authors: Lonial S; Kaufman J; Tighiouart M; Nooka A; Langston AA; Heffner LT; Torre C; McMillan S; Renfroe H; Harvey RD -
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters.
Leuk Lymphoma Volume: 51 Page(s): 1473 - 1477
08/01/2010 Authors: Tran H; Arellano M; Chamsuddin A; Flowers C; Heffner LT; Langston A; Lechowicz MJ; Tindol A; Waller E; Winton EF -
Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits?
Clin Lymphoma Myeloma Leuk Volume: 10 Page(s): 270 - 277
08/01/2010 Authors: Shenoy P; Sinha R; Tumeh JW; Lechowicz MJ; Flowers CR -
Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL).
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Flowers C; Taylor M; Hirata M; Dillon H; Zelenetz AD; Hainsworth JD; Cerhan JR; Rogers ES; Friedberg JW; Link BK -
Improving our use and understanding of antibodies in B-cell lymphomas.
Oncology (Williston Park) Volume: 24 Page(s): 176 - 177
02/01/2010 Authors: Flowers CR -
ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
Curr Probl Cancer Volume: 34 Page(s): 211 - 227
01/01/2010 Authors: Ng A; Constine LS; Advani R; Das P; Flowers C; Friedberg J; Hodgson DC; Schwartz CL; Wilder RB; Wilson LD -
Improving outcomes for patients with diffuse large B-cell lymphoma.
CA Cancer J Clin Volume: 60 Page(s): 393 - 408
01/01/2010 Authors: Flowers CR; Sinha R; Vose JM -
The Combination of Romidepsin and Bortezomib Results in Synergistic Induction of Apoptosis in Human B-Lymphoma Cell Lines.
Volume: 114 Page(s): 673 - 673
11/20/2009 Authors: Deshpande SS; Lechowicz MJ; Sinha R; Kaufman JL; Boise LH; Lonial S; Flowers CR -
The Addition of Bortezomib to Modified R-CHOP as Initial Therapy for Follicular NHL Results in High CR Rate and Is Well Tolerated
BLOOD Volume: 114 Page(s): 1432 - 1432
11/20/2009 Authors: Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Lonial S; Flowers CR -
Prognostic Significance of Circulating Lymphoma Cells in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Volume: 114 Page(s): 1151 - 1152
11/20/2009 Authors: Muringampurath-John D; Flowers CR; Jabbar AA; Sinha R; Arellano M; Bernal-Mizrachi L; Kaufman JL; Jaye DL; Chen Z; Lechowicz MJ -
A Comprehensive Identification of the Microrna Transcriptome and Its Application in B Cell Malignancies
Volume: 114 Page(s): 948 - 949
11/20/2009 Authors: Jacobs CL; Jima DD; Zhang J; Dunphy C; Richards KL; Choi WWL; Srivastava G; Evens AM; Gordon LI; Czader M -
Racial Differences in the Presentation and outcomes of Diffuse Large B-Cell Lymphoma in the United States
Volume: 114 Page(s): 370 - 370
11/20/2009 Authors: Malik N; Shenoy PJ; Bumpers K; Sinha R; Flowers CR -
Racial Disparities in Disease Presentation, Treatment, and Response Rates of Follicular Lymphoma (FL) in the United States (US): Report From the National LymphoCare Study (NLCS)
Volume: 114 Page(s): 562 - 563
11/20/2009 Authors: Nabhan C; Taylor M; Hirata J; Lin M; Parsons B; Flowers CR -
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.
J Clin Oncol Volume: 27 Page(s): 5023 - 5030
10/20/2009 Authors: de Vos S; Goy A; Dakhil SR; Saleh MN; McLaughlin P; Belt R; Flowers CR; Knapp M; Hart L; Patel-Donnelly D -
Assessing cost effectiveness of empirical and prophylactic therapy for managing leptospirosis outbreaks.
Epidemiol Infect Volume: 137 Page(s): 1323 - 1332
09/01/2009 Authors: Galloway RL; Levett PN; Tumeh JW; Flowers CR -
Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results.
J Clin Oncol Volume: 27 Page(s): 2
06/20/2009 Authors: Schuster SJ; Neelapu SS; Gause BL; Muggia FM; Gockerman JP; Sotomayor EM; Winter JN; Flowers CR; Stergiou AM; Kwak LW -
Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results
Volume: 27
06/20/2009 Authors: Schuster SJ; Neelapu SS; Gause BL; Muggia FM; Gockerman JP; Sotomayor EM; Winter JN; Flowers CR; Stergiou AM; Kwak LW -
Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results.
J Clin Oncol Volume: 27 Page(s): 2
05/20/2009 Authors: Schuster SJ; Neelapu SS; Gause BL; Muggia FM; Gockerman JP; Sotomayor EM; Winter JN; Flowers CR; Stergiou AM; Kwak LW -
Bortezomib plus modified R-CHOP as initial therapy for indolent B-cell lymphomas: Phase I results.
J Clin Oncol Volume: 27 Page(s): 8577
05/20/2009 Authors: Flowers C; Sinha R; Kaufman J; Shenoy P; Lewis C; Bumpers K; Rogatko A -
Bortezomib plus modified R-CHOP as initial therapy for indolent B-cell lymphomas: Phase I results
Volume: 27
05/20/2009 Authors: Flowers C; Sinha R; Kaufman J; Shenoy P; Lewis C; Bumpers K; Rogatko A -
Development of the Lymphoma Enterprise Architecture Database: a caBIG Silver level compliant system.
Cancer Inform Volume: 8 Page(s): 45 - 64
04/03/2009 Authors: Huang T; Shenoy PJ; Sinha R; Graiser M; Bumpers KW; Flowers CR -
Follicular lymphoma in the United States: first report of the national LymphoCare study.
J Clin Oncol Volume: 27 Page(s): 1202 - 1208
03/10/2009 Authors: Friedberg JW; Taylor MD; Cerhan JR; Flowers CR; Dillon H; Farber CM; Rogers ES; Hainsworth JD; Wong EK; Vose JM -
A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Am J Clin Oncol Volume: 32 Page(s): 49 - 55
02/01/2009 Authors: Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C -
EXTRACORPOREAL PHOTOPHERESIS THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE: RESPONSE IS ASSOCIATED WITH CONTENT OF DENDRITIC CELLS AND T-CELLS IN PERIPHERAL BLOOD AT INITIATION OF TREATMENT
Volume: 15 Page(s): 128 - 129
02/01/2009 Authors: Akhtari M; Giver CR; Renfroe HM; Langston AA; Khoury HJ; Flowers CR; Kaufman JL; Lonial S; Lechowicz MJ; Gleason CL -
A Randomized Phase I Study of Melphalan and Bortezomib for Autologous Transplant in Myeloma
CLINICAL LYMPHOMA & MYELOMA Volume: 9 Page(s): S60 - S60
02/01/2009 Authors: Kaufman JL; Lonial S; Sinha R; Torre C; Langston AA; Lechowicz MJ; Flowers C; McMillan S; Renfroe H; Heffner LT -
PHARMACOKINETIC (PK) COMPARISON OF INTRAVENOUS VERSUS ORAL BUSULFAN CONDITIONING REGIMENS FOR ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS) PATIENTS
Volume: 15 Page(s): 154 - 155
02/01/2009 Authors: Hutcherson DA; Surati M; Sanvidge K; Harvey D; Al-Baldawi RN; Langston A; Flowers C; Lonial S; Kaufman J; Lechowicz MJ -
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
BMC Health Serv Res Volume: 9 Page(s): 9
01/13/2009 Authors: Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR -
Does the Addition of Involved Field Radiotherapy to High-dose Chemotherapy and Stem Cell Transplantation Improve Outcomes for Patients with Relapsed/Refractory Hodgkin Lymphoma?
Volume: 75 Page(s): S480 - S480
01/01/2009 Authors: Kahn ST; Flowers C; Xu Z; Esiashvili N -
Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy.
Subst Abuse Volume: 3 Page(s): 41 - 51
01/01/2009 Authors: Reisman RM; Shenoy PJ; Atherly AJ; Flowers CR -
Lymphoma and Whole Body CT Scan Mortality Risk
Volume: 112 Page(s): 477 - 478
11/16/2008 Authors: Shenoy PJ; Gude T; Sinha R; Flowers CR -
A Randomized Phase I Trial of Melphalan plus Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration
Volume: 112 Page(s): 1144 - 1145
11/16/2008 Authors: Lonial S; Kaufman J; Torre C; Langston A; Lechowicz MJ; Flowers C; McMillan S; Renfroe H; Heffner LT; Waller EK -
Examining Decision Making Styles in Patients with Sickle Cell Disease (SCD) Regarding Allogeneic Stem Cell Tranplantation (ASCT)
Volume: 112 Page(s): 69 - 69
11/16/2008 Authors: Agboola OA; Shenoy PJ; Edwards PJ; Eckman JR; Flowers CR -
Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study
Volume: 112 Page(s): 1247 - 1247
11/16/2008 Authors: Langston AA; Murali S; McMillan S; Heffner LT; Lonial S; Waller EK; Flowers CR; Kaufman J; McLemore ML; Sinha R -
Higher Numbers of Circulating Dendritic Cells and T-Cells Predict Response to Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease
Volume: 112 Page(s): 432 - 432
11/16/2008 Authors: Giver CR; Akhtari M; Langston AA; Khoury HJ; Flowers CR; Kaufman JL; Lonial S; Lechowicz MJ; Gleason CL; Vaughn ML -
Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States.
Leuk Lymphoma Volume: 49 Page(s): 2099 - 2107
11/01/2008 Authors: Abouyabis AN; Shenoy PJ; Lechowicz MJ; Flowers CR -
Clinical Laboratory Validation of InVivoScribe LymphotrakTM IgH TrackTwoTM Assays for the Detection of Minimal Residual Disease in CLL/SLL
Volume: 10 Page(s): 584 - 584
11/01/2008 Authors: Cole JM; Sinha R; Flowers C; Mann K -
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
Bone Marrow Transplant Volume: 42 Page(s): 529 - 534
10/01/2008 Authors: Murali S; Winton E; Waller EK; Heffner LT; Lonial S; Flowers C; Kaufman J; Arellano M; Lechowicz MJ; Mann KP -
Idiotype vaccine strategies for improving outcomes in follicular lymphoma.
Expert Opin Biol Ther Volume: 8 Page(s): 1213 - 1223
08/01/2008 Authors: Sinha R; Shenoy PJ; Flowers CR -
The prognostic significance of donor dendritic cells in allogeneic hematopoietic progenitor cell transplant
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Dejoubner N; Ali Z; Grasier M; Hamilton E; Flowers C; Lonial S; Langston A; Waller EK -
Routine scans for lymphoma produce minimal radiation-related cancer mortality risk
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Shenoy P; Halkar R; Wilson S; Flowers C -
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
J Clin Oncol Volume: 25 Page(s): 5490 - 5505
12/01/2007 Authors: Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H -
The effect of rituximab on mobilization with AMD3100 plus G-CSF in patients with relapsed or refractory NHL or HD
Volume: 110 Page(s): 568A - 568A
11/16/2007 Authors: Kaufman JL; Cook AM; Flowers C; Langston AA; Lonial S; Lechowicz MJ; Khoury HJ; Calandra G; Waller N -
Analysis of minimal residual disease (MRD) from the phase 2 multicenter study of subcutaneous (SC) alemtuzumab combined with fludarabine for treatment of relapsed/refractory B-cell chronic lymphocytic leukemia (CLL).
Volume: 110 Page(s): 915A - 915A
11/16/2007 Authors: Flowers C; Rosenthal H; Brown J; Stock W; Katzen H; Lakhanpal S; Jaye D -
A randomized phase I trial of Melphalan plus Bortezomib as conditioning for autologous transplant for myeloma: The effect of sequence of administration
Volume: 110 Page(s): 288A - 289A
11/16/2007 Authors: Lonial S; Kaufman J; Langston A; Heffner LT; Torre C; Lechowicz MJ; Flowers C; McMillan S; Arnold M; Waller NK -
Examining decision making styles in patients with lymphoma and multiple myeloma considering autologous stem cell transplantation
Volume: 110 Page(s): 975A - 976A
11/16/2007 Authors: Agboola OA; Edwards P; Flowers CR -
Therapeutic drug monitoring (TDM) of IV busulfan in patients with severe obesity
Volume: 110 Page(s): 592A - 592A
11/16/2007 Authors: Hutcherson DA; Sessions JK; Mihelic RA; Sanvidge K; Stricker SR; Langston A; Flowers C; Lechowicz MJ; Waller N; Lonial S -
Maintenance therapy in lymphoma.
Clin Lymphoma Myeloma Volume: 7 Page(s): 507 - 513
09/01/2007 Authors: Mihelic R; Kaufman J; Lonial S; Flowers C -
Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation.
Biol Blood Marrow Transplant Volume: 13 Page(s): 895 - 904
08/01/2007 Authors: Ninan MJ; Flowers CR; Roback JD; Arellano ML; Waller EK -
Racial variation in colorectal polyp and tumor location.
J Natl Med Assoc Volume: 99 Page(s): 723 - 728
07/01/2007 Authors: Thornton JG; Morris AM; Thornton JD; Flowers CR; McCashland TM -
The occurrence of idiopathic secondary post-transplant thrombocytopenia and the kinetics of platelet recovery predict survival in patients undergoing autologous hematopoietic progenitor cell transplantation
Volume: 25
06/20/2007 Authors: Waller E; Ninan MJ; Roback J; Arellano M; Flowers C -
Cost-effectiveness of tositumomab and iodine I-131 tositumomab (Bexxar therapeutic regimen (BTR)), in treatment of non-Hodgkin lymphoma (NHL)
Volume: 25
06/20/2007 Authors: Flowers CR; Sambrook JC; Briggs A; Osenenko K; Wang H; Dalal MR -
BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
Expert Rev Vaccines Volume: 6 Page(s): 307 - 317
06/01/2007 Authors: Flowers CR -
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience.
Biol Blood Marrow Transplant Volume: 13 Page(s): 746 - 747
06/01/2007 Authors: Santos EC; Sessions J; Hutcherson D; Flowers C; Langston A; Waller EK -
Development of query strategies to identify a histologic lymphoma subtype in a large linked database system.
Cancer Inform Volume: 3 Page(s): 149 - 158
05/04/2007 Authors: Graiser M; Moore SG; Victor R; Hilliard A; Hill L; Keehan MS; Flowers CR -
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. (vol 47, pg 629, 2007)
TRANSFUSION Volume: 47 Page(s): 952 - 952
05/01/2007 Authors: Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi SS; Teagarden D; Hamilton ES; Waller EK -
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
Transfusion Volume: 47 Page(s): 629 - 635
04/01/2007 Authors: Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK -
A randomized phase I trial of melphalan plus bortezomib as conditioning for autologous transplant for myeloma: The effect of sequence of administration
Volume: 13 Page(s): 56 - 56
02/01/2007 Authors: Lonial S; Kaufman J; Langston AA; Khoury HJ; Torre C; Lechowicz MJ; Flowers C; Waller EK -
Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Biol Blood Marrow Transplant Volume: 13 Page(s): 116 - 123
01/01/2007 Authors: Arellano ML; Langston A; Winton E; Flowers CR; Waller EK -
Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy.
Value Health Volume: 10 Page(s): 23 - 31
01/01/2007 Authors: Moore S; Tumeh J; Wojtanowski S; Flowers C -
Race and disparities in health.
Curr Probl Cancer Volume: 31 Page(s): 114 - 122
01/01/2007 Authors: Brawley OW; Jani AB -
Racial differences in the incidence and outcomes for patients with hematological malignancies.
Curr Probl Cancer Volume: 31 Page(s): 182 - 201
01/01/2007 Authors: Flowers CR; Glover R; Lonial S; Brawley OW -
Phase 2 study of bortezomib weekly or twice weekly plus rituximab in patients with follicular (FL) or marginal zone (MZL) lymphoma: Final results.
Volume: 108 Page(s): 208A - 208A
11/16/2006 Authors: De Vos S; Dakhil SR; McLaughlin P; Saleh MN; Belt R; Flowers C; Holladay C; Knapp M; Boral A; Zhang T -
Tolerability and anti-leukemic activity of ara-C, topotecan, and gemtuzumab ozogamicin [ATGO] in advanced MDS and AML: Interim analysis of phase I/II data.
Volume: 108 Page(s): 554A - 554A
11/16/2006 Authors: Murali S; Winton EF; McMillan S; Lonial S; Waller N; Heffner L; Flowers C; Kaufman JL; Lechowicz MJ; Khoury HJ -
Mechanism for the immuno-suppresion activity of pentostatin: Selective apoptosis of naive T cell subsets.
BLOOD Volume: 108 Page(s): 380B - 380B
11/16/2006 Authors: Smith MM; Powers W; Giver CR; Waller N; Flowers C -
Patients receiving patifermin in conjunction with melphalan 200 required fewer platelet transfusions: Analysis of a retrospective cohort study.
Volume: 108 Page(s): 407B - 407B
11/16/2006 Authors: Hutcherson DA; Langston A; Lin CH; Flowers C; Lechowicz MJ; Waller N; Sessions JK; Kaufman JL; Jean Khoury H; Lonial S -
Impact of revised international working group criteria on lymphoma patients undergoing autologous stem cell transplantation.
Volume: 108 Page(s): 873A - 873A
11/16/2006 Authors: Lucas AS; Flowers C; Langston A; Lonial S; Lechowicz MJ; Waller N; Kaufman JL; Jean Khoury H -
Determining the benefits of rituximiab plus chemotherapy for patients with untreated follicular lymphoma: A comprehensive meta-analysis.
Volume: 108 Page(s): 950A - 950A
11/16/2006 Authors: Orina JN; Flowers CR -
Early estimates of safety for alemtuzumab combined with fludarabine for the treatment of relapsed/refractory B-cell chronic lymphocytic leukemia: Phase II multicenter study.
Volume: 108 Page(s): 336B - 336B
11/16/2006 Authors: Brown JR; Stock W; Katzen HI; Suarez AJ; Lakhanpal S; Leis JF; Flowers C -
Benefits of CHOP-14 followed by transplantation in patients with peripheral T-cell lymphoma.
Volume: 108 Page(s): 254B - 254B
11/16/2006 Authors: Abouyabis AN; Lechowicz M; Mann K; Heffner LT; Winton E; Bucur S; Flowers CR -
A randomized trial to evaluate the impact of cytokines (G-CSF or GM plus G-CSF) on dendritic cell and T-Cell content and function when mobilizing normal donors for allogeneic progenitor cell transplant.
Volume: 108 Page(s): 964A - 964A
11/16/2006 Authors: Lonial S; McMillan S; Torre C; Langston AA; Hamilton E; Cook A; Flowers C; Kaufman JL; Lechowicz MJ; Waller N -
T cell reconstitution in first 200 days post transplantation predicts long term survival in allogeneic hematopoetic progenitor cell transplantation (HPCT).
Volume: 108 Page(s): 920A - 920A
11/16/2006 Authors: Vann L; Larks M; Flowers C; Lonial S; Kaufman J; Lechowicz MJ; Langston AA; Khoury J; Waller N -
Infliximab for the treatment of chronic graft versus host disease.
Volume: 108 Page(s): 818A - 818A
11/16/2006 Authors: Tolbert E; Waller N; Khoury HJ; Lechowicz MJ; Flowers C; Lonial S; Vann L; Langston A; Kaufman JL -
Value of PET restaging after chemotherapy for non-Hodgkin's lymphoma: implications for consolidation radiotherapy.
Int J Radiat Oncol Biol Phys Volume: 66 Page(s): 961 - 965
11/15/2006 Authors: Kahn ST; Flowers C; Lechowicz MJ; Hollenbach K; Johnstone PAS -
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
Leuk Lymphoma Volume: 47 Page(s): 2155 - 2162
10/01/2006 Authors: Lonial S; Arellano M; Hutcherson D; Langston A; Flowers C; Heffner LT; Winton E; Jo Lechowicz M; Waller EK -
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
J Clin Oncol Volume: 24 Page(s): 6060
06/20/2006 Authors: Moore SG; Tumeh J; Flowers CR -
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
Volume: 24 Page(s): 315S - 315S
06/20/2006 Authors: Moore SG; Tumeh J; Flowers CR -
A randomized phase I trial of melphalan + bortezomib as conditioning for autologous transplant for myeloma.
J Clin Oncol Volume: 24 Page(s): 17550
06/20/2006 Authors: Kaufman JL; Waller EK; Torre C; McMillan S; Langston A; Flowers C; Lechowicz M; Tighiouart M; Lonial S -
Receiver operator characteristics of the Sysmex HPC measurement used to initiate apheresis of blood hematopoietic progenitor cells
Volume: 12 Page(s): 10 - 10
02/01/2006 Authors: Hamilton ES; Flowers CR; Vaughn ML; Minerley M; Waller EK -
Idiopathic secondary post-transplant thrombocytopenia (ISPT) following autologous hematopoietic progenitor cell transplantation (HPCT) is associated with transplantation of lower numbers of primitive hematopoietic progenitors
Volume: 12 Page(s): 132 - 132
02/01/2006 Authors: Ninan MJ; Arellano M; Philip A; Langston A; Flowers CR; Lonial S; Kaufman J; Lechowicz M; Khoury JH; Roback J -
Reduced-intensity conditioning permits a significant graft vs leukemia (GvL) effect for acute leukemia
Volume: 12 Page(s): 69 - 70
02/01/2006 Authors: Arellano M; Flowers C; Waller E; Lonial S; Kaufman J; Winton E; Khoury H; Langston A -
Decreased incidence of relapse in patients with acute leukemia transplanted from matched unrelated donors: Induction of GvL
Volume: 106 Page(s): 570A - 571A
11/16/2005 Authors: Arellano ML; Langston A; Lonial S; Flowers C; Khoury JH; Winton E; Waller EK; Mary LJ -
A randomized trial to evaluate the impact of cytokines (G-CSF or GM plus GCSF) on dendritic cell and T-cell content and function when mobilizing normal donors for allogeneic progenitor cell transplant
Volume: 106 Page(s): 555A - 555A
11/16/2005 Authors: Lonial S; Torre C; Langston AA; McMillans S; Hamilton E; Flowers C; Lechowicz MJ; Waller EK -
Determining the benefits of chemotherapy for achieving complete response in patients with untreated advanced stage follicular lymphoma: A systematic review and meta-analysis.
Volume: 106 Page(s): 88A - 89A
11/16/2005 Authors: Orina JN; Moore SG; Lechowicz MJ; Flowers CR -
Relapse free survival of elderly AML patients is comparable to that of younger adults when treated with a modified dose intensive cytarabine regimen.
Volume: 106 Page(s): 237B - 237B
11/16/2005 Authors: Langston AA; Heffner LT; Hutcherson D; Neely J; Flowers C; Waller EK; Lonial S; Khoury HJ; Winton E -
Systematic review and meta-analysis of radioimmunotherapy regimens in patients with relapsed follicular and transformed nonhodgkins lymphomas.
Volume: 106 Page(s): 870A - 871A
11/16/2005 Authors: Orina JN; Moore SG; Lechowicz MJ; Flowers CR -
Ex vivo fludarabine selectively depletes human naive T-Cell subsets: A step toward modifying donor lymphocyte infusion.
Volume: 106 Page(s): 312A - 312A
11/16/2005 Authors: Smith MM; Giver CR; Waller EK; Flowers CR -
Patient characteristics in CD 20(+) and CD 20(-) adult acute lymphoblastic leukemia (ALL): A single institution analysis.
Volume: 106 Page(s): 210B - 210B
11/16/2005 Authors: Gladney SP; Heffner LT; Langston A; Holden J; Phillips C; Winton E; Flowers CR; Lechowicz MJ; Lonial S; Waller E -
Assessing the cost-effectiveness of adding aprepitant to the ASCO standard for prophylaxis of chemotherapy induced nausea and vomiting.
Volume: 23 Page(s): 530S - 530S
06/01/2005 Authors: Moore SG; Tumeh JW; Woftanowski S; Flowers CR -
Results of a clinical phase I dose-escalation study of cylarabine in combination with fixed dose vinorelbine, paclitaxel, etoposide, and cisplatin (VTEPA) for the treatment of relapsed/refractory lymphoma.
Volume: 23 Page(s): 607S - 607S
06/01/2005 Authors: Arellano ML; Lonial S; Langston A; Flowers C; Heffner T; Hutcherson D; Winton E; Waller E -
Practical approach for using Medicare data to estimate costs for cost-effectiveness analysis.
Expert Rev Pharmacoecon Outcomes Res Volume: 5 Page(s): 153 - 162
04/01/2005 Authors: Tumeh JW; Moore SG; Shapiro R; Flowers CR -
Rituximab does not inhibit chemo-mobilization of HPC or engraftment following autologous transplant for lymphoma
Volume: 11 Page(s): 6 - 6
02/01/2005 Authors: Kaufman JL; Lonial S; Hicks M; Langston A; Flowers C; Lechowicz MJ; Khoury H; Waller EK -
Value of PET restaging after chemotherapy for non-Hodgkins lymphoma: Implications for consolidation radiotherapy
Volume: 63 Page(s): S422 - S422
01/01/2005 Authors: Kahn S; Koshy M; Flowers C; Lechowicz M; Hollenbach K; Johnstone PA -
Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.
Cancer J Volume: 11 Page(s): 425 - 431
01/01/2005 Authors: Kahn ST; Flowers CR; Lechowicz MJ; Hollenbach K; Johnstone PAS -
A phase I trial of ara-C, topotecan, and gemtuzumab ozogamicin (Mylotarg (R)) for advanced MDS and secondary or relapsed AML.
Volume: 104 Page(s): 502A - 502A
11/16/2004 Authors: Langston AA; McMillan S; Lonial S; Smith K; Waller EK; Heffner LT; Bucur S; Redei I; Flowers C; Lechowicz MJ -
Predictors of more rapid lymphoid reconstitution after allogeneic transplantation
Volume: 104 Page(s): 864A - 864A
11/16/2004 Authors: Arellano ML; Moore SG; Kudchadkar R; Flowers CR; Langston AA; Lonial S; Lechowicz MJ; Waller EK -
A randomized trial to evaluate the impact of cytokines on dendritic cell, T-cell and T-cell function when mobilizing normal donors for allogeneic progenitor cell transplant: An interim analysis.
Volume: 104 Page(s): 780A - 780A
11/16/2004 Authors: Lonial S; Torre C; Hicks M; Mcmillan S; Langston AA; Flowers CR; Lechowicz MJ; Waller EK -
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Blood Volume: 104 Page(s): 1550 - 1558
09/01/2004 Authors: Diaconescu R; Flowers CR; Storer B; Sorror ML; Maris MB; Maloney DG; Sandmaier BM; Storb R -
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Blood Volume: 104 Page(s): 961 - 968
08/15/2004 Authors: Sorror ML; Maris MB; Storer B; Sandmaier BM; Diaconescu R; Flowers C; Maloney DG; Storb R -
The role of cost-effectiveness analysis in the era of pharmacogenomics.
Pharmacoeconomics Volume: 22 Page(s): 481 - 493
01/01/2004 Authors: Flowers CR; Veenstra D -
Morbidity and mortality with nonmyeloablative compared to myeloablative conditioning before hematopoietic cell transplantation from HLA matched related donors.
Volume: 102 Page(s): 77A - 78A
11/16/2003 Authors: Diaconescu R; Flowers C; Storer B; Sorror ML; Maris M; Maloney DG; Chauncey T; Sandmaier BM; Storb RF -
Transplant-related Toxicities (TRT) and mortality following HLA matched unrelated donor hematopoietic cell transplantation (URD-HCT) using nonmyeloablative (NM) compared to myeloablative (M) conditioning: Influence of pretransplant comorbidities.
Volume: 102 Page(s): 78A - 78A
11/16/2003 Authors: Sorror ML; Maris M; Storer B; Sandmaier BM; Diaconescu R; Flowers C; Maloney DG; Storb RF -
Can pharmacogenomics be cost-effective?: An analysis of genotype-individualized therapy for children with acute lymphoblastic leukemia.
Volume: 102 Page(s): 496A - 496A
11/16/2003 Authors: Flowers CR; Veenstra DL -
Comparing the cost-effectiveness of the triple test score to traditional methods for evaluating palpable breast masses.
Med Care Volume: 41 Page(s): 962 - 971
08/01/2003 Authors: Morris AM; Flowers CR; Morris KT; Schmidt WA; Pommier RF; Vetto JT -
Racial variation in colorectal polyp and tumor location: Implications for screening
AMERICAN JOURNAL OF GASTROENTEROLOGY Volume: 97 Page(s): S244 - S244
09/01/2002 Authors: Gore JI; Morris A; Flowers CR; Thornton JD; McCashland TM -
Allogeneic hematopoietic stem cell transplantation with nonmyeloablative conditioning for patients with chronic lymphocytic leukemia.
BLOOD Volume: 98 Page(s): 418A - 418A
11/16/2001 Authors: Flowers CR; Maloney DG; Sandmaier BM; Shizuru JA; McSweeney PA; Chauncey TR; Niederwieser D; Sahebi F; Agura E; Blume K -
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Ann N Y Acad Sci Volume: 938 Page(s): 328 - 337
06/01/2001 Authors: Feinstein L; Sandmaier B; Maloney D; McSweeney PA; Maris M; Flowers C; Radich J; Little MT; Nash RA; Chauncey T -
Regimen related toxicities associated with nonmyeloablative conditioning and postgrafting cyclosporine and mycophenolate mofetil.
BLOOD Volume: 96 Page(s): 521A - 521A
11/16/2000 Authors: Flowers CR; Sandmaier BM; Maloney DG; Shizuru JA; Niederwieser D; McSweeney PA; Chauncey TR; Sahebi F; Blume K; Forman S -
Cyclosporin and the clinical investigator.
Nat Med Volume: 3 Page(s): 590
06/01/1997 Authors: Sthelin HF -
Clinical investigators as critical determinants in pharmaceutical innovation.
Nat Med Volume: 3 Page(s): 136 - 143
02/01/1997 Authors: Flowers CR; Melmon KL -
Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems.
Proc AMIA Annu Fall Symp Page(s): 223 - 227
01/01/1997 Authors: Flowers CR; Garber AM; Bergen MR; Lenert LA -
Neurochemical predictors and correlates of vulnerability to cocaine use.
NIDA Res Monogr Volume: 159 Page(s): 228 - 263
01/01/1996 Authors: King RJ; Flowers C -
IMPACT: an object-oriented graphical environment for construction of multimedia patient interviewing software.
Proc Annu Symp Comput Appl Med Care Page(s): 319 - 323
01/01/1995 Authors: Lenert LA; Michelson D; Flowers C; Bergen MR -
13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 7-8 November 2011. Abstracts.
Authors: Zhang J; Grubor V; Love CL; Banerjee A; Richards KL; Miezcowski P; Dunphy CH; Choi WWL; Auv W-Y; Srivastava G